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30TH BETHESDA CONFERENCE
Introduction
Kenneth Lee Baughman, MD, FACC, Conference Co-Chair,
Michael H. Crawford, MD, FACC, Conference Co-Chair
Academic cardiology has been largely responsible for the
medical advances which have resulted in the dramatic
decline in death rates from cardiovascular disease over the
last 30 years in the United States. Changes in the health
care environment including managed care, decreased phy-
sician payment for patient care activities, diminished indus-
try support and a stringent regulatory environment have had
a profound effect on the academic medical center. These
changes have reduced funding for medical research and the
training of physicians and have pitted the academic medical
centers against the private sector in competition for patients
and scarce health care resources. Most academic centers
were ill equipped to deal effectively with these changes.
Consequently some have declared bankruptcy, and many are
in financial crisis. The American College of Cardiology has
grown increasingly concerned about the effect of the current
environment on the nation’s academic cardiology programs.
The 30th Bethesda Conference “The Future of Academic
Cardiology” was convened to address these concerns. The
conference organizers assembled cardiologists from aca-
demic medical centers and the private sector as well as
experts from organized medicine, industry, government and
payers. The purpose of the Bethesda Conference was not
only to define market force corrections necessary for the
survival of academic cardiology, but also to formulate a
paradigm that would sustain academic medical centers into
the next millennium.
The tripartite mission of academic cardiology is to train
adult and pediatric cardiologists, to conduct research in
cardiovascular diseases and to provide secondary and tertiary
patient care. Although all academic programs share these
missions, medical centers differ in their ability to support all
of the missions well. In addition, some are state supported,
others are private institutions, and others are hospital-based
training programs not associated with a university medical
center. Thus, not all of the recommendations put forth in
this document will be applicable to each academic cardiol-
ogy program. However, the conference did attempt to
provide basic principles that should guide the future devel-
opment of academic cardiology. Although the document is
primarily directed toward the future of academic cardiology,
there may be aspects that would be of value to other
specialties and the academic enterprise.
To sustain academic cardiology in the future, a new
paradigm must be developed within the academic medical
center. This paradigm encourages product line development
and integration across divisions and traditional departments.
The product line integration would include all three mis-
sions of academic cardiology including patient care, research
and teaching. The product line concept would allow a
seamless transition of patients through the health care
system with an integrated approach eliminating duplication
of effort and allowing cost savings. Not only patient care
resources, but also those used for teaching, research and
administration would be consolidated. Traditional relation-
ships would exist between product line divisions and their
academic departments for promotion, teaching and taxa-
tion. However, some expenses previously supported by
departments would be assumed by the product line entity
and taxation reduced appropriately. Product line develop-
ment could expand to other entities within the academic
medical center such as gastroenterologic services and thor-
acic care.
The conference participants strongly believed that the
traditional medical school expectations that faculty excel in
all three academic missions are no longer relevant in the
current academic milieu. The expansion of the knowledge
base in all three areas, the dedication necessary to make each
area financially self-sustaining and the effort required to stay
at the cutting edge of each of these endeavors make the
individual capable of succeeding in all three an anachronism.
Likewise, the conference participants believed that the
model which demands research faculty members make brief
appearances on the wards or in the clinic a few times a year
is not an adequate model for the training and patient care
missions of the institution. Nor is the clinician who per-
forms a few experiments funded by clinical earnings a useful
model for advancing the science of cardiovascular disease.
Specialization in one or two of the missions is required, and
consequently most medical schools have developed faculty
tracks such as the clinician–educator, the clinician–scholar
or the research scientist.
The conference participants believed that each of these
academic tracks should have its own criteria for evaluating
faculty performance, its own criteria for promotion and its
own concept of tenure or job security. The classic tenure
track also is anachronistic. Although the conference be-
lieved that some element of job security was important, the
traditional tenure system should be reevaluated. A review
policy to make sure that the faculty member is still perform-
ing at the level that originally granted them tenure and
adjustment in salary or position retention based on this
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review should be initiated. Also, faculty must be trained to
function as part of a team with other health care profes-
sionals and workers. All on the team should be respected for
their unique contribution to the enterprise and a spirit of
collegiality developed. Finally, those who attended the
conference were very concerned that academic cardiology is
not attracting large numbers of women and minorities and
believed that increased sensitivity to the special needs of
these groups needs to be taken into consideration in the
future academic cardiology model.
The survival of academic cardiology is dependent on the
operation of the entity as a business. Patient care revenues
which previously were used to support the teaching and
research mission are no longer available. Specifically, bud-
gets must be developed to support teaching, research,
patient care and administration. Those components of the
mission most in jeopardy are teaching and the support of
young investigators. The teaching performed by the cardio-
vascular faculty must be quantitated and segregated into that
which is integrated into, and that which is separate and
distinct from, patient care activities. The proportion of
Medicare Part A funds intended for faculty supervision of
patient care and teaching should be directed toward those
performing these activities. Endowment funds should be
raised specifically to fund young investigators and to pro-
mote dedicated teaching activities. There must be an align-
ment of the incentives between the cardiology sections, the
health care system and the academic hospitals. This align-
ment may allow resources to be allocated to cardiology
sections to support appropriate activities which directly and
indirectly benefit the health care system. Finally, it is
important that the leaders of future academic cardiology
sections or cardiovascular institutes be trained as business
persons capable of understanding the intricacies of health
care finance.
A collaborative arrangement with physicians in the pri-
vate sector is important for all three missions of academic
cardiology. The academic cardiology section needs help
with teaching, especially that performed by accomplished
clinicians in outpatient venues. Practitioners can help with
the recruitment of patients for clinical trials and other
clinical research activities that will not only increase the
number of patients in the trials, but will bring new treat-
ments and procedures to a broader spectrum of subjects.
Finally, private physicians can help maintain an adequate
volume of patients at the academic center to sustain its
missions by helping to support clinical activities in collab-
oration with the academic center. An example of such an
activity may be cardiac transplantation or a highly special-
ized and investigational technique such as transmyocardial
revascularization. This collaboration should be accom-
plished in a fashion that allows all involved to benefit from
the interaction, including the practitioner and his or her
patient. Some academic medical centers have developed
strong collaborative relationships with practitioners, includ-
ing shared resource and clinical care business opportunities.
Although the conference participants realized that this
collaboration with the private sector will be a challenge in
today’s highly competitive markets, they believed that this is
the only system that would insure the sustained success of
academic cardiology.
The academic medical center should be preserved by the
health care system and supported by academic cardiology.
Although some of the research and teaching missions and
much of the patient care can be accomplished in peripheral
institutions, the academic medical center embodies certain
features that warrant its continuation and support. The
academic medical center’s primary role is the maintenance
of a milieu of research investigation, innovation and teach-
ing throughout all of its activities. This milieu and colla-
boration has spawned many of the discoveries that have
dramatically influenced science and ultimately, patients.
This milieu cannot be maintained in a dispersed system that
does not support all three primary missions as core objec-
tives.
The American public, and many involved in health care
finance, are unaware of the true cost of research and
education. It is important that the true educational cost
associated with the production of a cardiologist be accu-
rately determined. The value of these trained cardiologists,
most of whom will ultimately practice in the community,
must be defined. The importance of the allocation of the
cost of training to the public and payers must be justified by
the value to the community. Similarly, the rigorous nature
of basic investigation and clinical research needs to be
transmitted to the American people, who ultimately support
and benefit from research investigation. Only through such
educational efforts can the support that academic cardiology
sections have received in the past be preserved or enhanced
in the future.
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TASK FORCES
Task Force 1: Clinical Care
Henry DeMots, MD, FACC, Co-Chair, Gilbert H. Mudge, Jr., MD, FACC, Co-Chair
PURPOSE OF CLINICAL CARE IN
THE ACADEMIC MEDICAL CENTER
Academic cardiovascular programs are currently defined as
subspecialty programs committed to advancing clinical care,
promoting innovative basic and clinical research and foster-
ing comprehensive teaching of all health care professionals
in cardiovascular diseases. The unique integration of these
commitments distinguishes an academic medical center
from community hospitals, research foundations and phar-
maceutical companies and enhances the opportunities to
improve overall medical care. Academic cardiovascular pro-
grams provide optimal patient care by applying state-of-the-
art technology, the most recent advances in medical science
and the medical expertise of acknowledged opinion leaders
and experienced clinicians. Such programs may or may not
be associated with a university or a single teaching hospital,
may vary in relationships to community health care provid-
ers and may or may not have single leadership, but all
remain committed as their primary purpose to all three
missions. A critical mass of both expertise and clinical
challenges in an environment of questioning is central to its
success.
Indeed, academic cardiovascular programs have been
highly successful in achieving the goals of each of these
three missions. Over the past several decades, academic
cardiovascular programs have trained large numbers of
excellent clinicians who have taken their expertise into the
community, effected major changes in the care of patients
with cardiovascular disease through innovative translational
research and developed high technology approaches to the
care of patients with cardiovascular disease, resulting in
improved outcomes with lower mortality and morbidity and
at decreased costs. Paradoxically, it is these successes that in
many ways have led to the conundrum now facing the
academic cardiovascular program. Their success in training
cardiovascular specialists and appropriately exporting exper-
tise and technology to the community now makes it
increasingly difficult for academic cardiovascular divisions to
be differentiated from other providers on the basis of quality
of care and to compete on an economic basis without
differentiation despite the costs of education and an increas-
ing number of indigent patients. To confront these assorted
pressures, some academic cardiovascular divisions have at-
tempted to increase clinical volume, which has stressed
traditional missions of teaching and research. The necessary
changes in staff requirements or in academic expectations
have not been made, further confusing mission and long-
term goals.
In the earlier era of fee-for-service reimbursements,
cardiovascular divisions provided substantial revenues for
both the academic medical center as well as for non–
revenue-generating divisions within the departments of
medicine or pediatrics. Furthermore, many academic cen-
ters had a virtual monopoly on high technology services
including interventional coronary procedures and high risk
coronary revascularization. Professional revenues as well as
public resources were readily available to support dedicated
faculty, and to provide high quality teaching and outstand-
ing clinical care. But revolutionary changes in the organi-
zation and delivery of medical care in this country threaten
the integrity of the academic medical center, necessitating
recent restructuring of purpose and redefinition of mission
to be a more integral component of health care delivery
systems (1–4). Recent catastrophic failures have resulted
from academic medical centers failing to establish links,
isolating themselves in an adversarial managed care envi-
ronment (5) and being too late in recognizing the strength
of partnering with community providers.
Current organizational structures of academic medical
centers compound the dilemmas of the current cardiovas-
cular academic division (6). Diminished third party reim-
bursements, decreased public funding for training and
smaller profit margins on high technology procedures have
resulted in substantial decreases in cardiology-based reve-
nues. Without an accompanying decrease in cost shifting
within the academic department of medicine/pediatrics,
divisions of cardiology are still held responsible for subsi-
dizing non–revenue-generating divisions within the depart-
ments and are held accountable to a different economic
standard, making it impossible for academic cardiology
divisions to be competitive with community specialists on
an equitable footing.
Academic cardiovascular divisions have also traditionally
had a monopoly on investigational drugs, biologics and
devices. They used superspecialized physicians possessing a
unique knowledge base compared with the community, but
this expertise has become more readily available. Investiga-
tional device, drug and biologic sponsors have found enroll-
ment of patients at times easier in the community hospital
with lower overhead, fewer bureaucratic impediments and
more ready access to patients and have moved their studies
to these new partners who have physicians of comparable
expertise.
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In the next decade, academic cardiovascular programs
must pursue business-like practices and compete aggres-
sively within the market if the traditional mission is to be
sustained. Such competition should be in partnership with
other colleagues within the academic medical center or in
community hospitals. They must restructure relationships
within and outside the academic medical center to meet
these challenges. This will require modification in external
relationships as well as internal organization summarized as
follows:
External relationships.
● Multidisciplinary integration of programs and personnel
that may not always be in the division of cardiology or
departments of medicine/pediatrics aligned with product
line services.
● Effective integration/coordination with nonacademic col-
leagues to accomplish teaching, research and patient care,
redrawing the boundaries of academic cardiovascular pro-
grams.
● Effective relationships fostered by mutual respect of
individual contributions to a joint purpose, where finan-
cial relationships may be but one component of this
relationship.
● Reconnect with primary patient populations through
excellence of clinical products and fiscally sound relation-
ships.
Internal restructuring.
● Development of cardiovascular units to include personnel
and programs separate from the departments of medicine/
pediatrics whose fiscal and governing structure optimizes
the likelihood of success.
● Leveraging intellectual capital by developing new or more
effective business products (e.g., disease management,
faculty-owned companies or an expanded model of clin-
ical research).
● Active support for development of clinical performance
measures and outcomes that result in benchmarks.
This report will assess these opportunities, recognizing
the variation in needs from community to community. Such
long-term restructuring of academic cardiovascular pro-
grams will be central to the success of all cardiovascular
specialists and will improve the access of all patients to the
best cardiovascular care.
CURRENT CHALLENGES
General Considerations
Although community providers are under the same ultimate
financial constraints, the academic cardiovascular program
has unique challenges that must be addressed. These include
the following:
1. The funding mechanisms for medical education are
unclear and differentially burden the cost of medical
education to academic medical centers, yet all payers
benefit from the products of this education process.
2. The current decision-making process in academic or-
ganizations is often bureaucratic, cumbersome and too
slow for rapid response to changes in the marketplace.
3. Multiple agendas within an academic medical center
and the multiplicity of priorities and commitments
often make response to market forces slow and tedious.
4. The ability of each academic department within an
academic medical center to delay or stall critical deci-
sions burdens the deliberations.
5. Due to more limited and focused agendas, for-profit
institutions and other health care systems without the
academic medical center overhead and mission have
more effectively invested resources in competitive strat-
egies for clinical care.
6. Academic medical centers have traditionally relied on
quality of care as a differentiating factor, but such
quality is often difficult to measure and exists in the
community.
7. The multiple agendas and missions within an academic
medical center dilute the focus on clinical care. In many
departments of medicine/pediatrics, for example, em-
phasis has been restricted to research productivity at the
expense of developing appropriate clinical and teaching
programs.
8. Rigid stratification of teaching techniques/paradigms
also limits any advantage of an academic medical center.
9. The additional cost of training house staff and students
is above and beyond the costs of medical care without a
structure to finance this commitment.
10. Relationships between academic medical centers and
community providers have often been strained and
ineffective.
11. Academic medical centers strive to develop a profile of
tertiary and quaternary care which inherently provides
them with adverse selection, and high acuity of illness.
In an environment of capitation and prospective pay-
ments, such adverse selection may be detrimental to the
survival of the academic medical center.
12. Academic medical centers have often focused on care of
the underinsured and fragile population, constituents of
our society who are by and large ignored by the current
forces of managed care and other payers. Research
performed by the Association of American Medical
Colleges suggests that the burden of this care in
academic medical centers is increasing and may be of
major consequence for the future of the academic
program.
13. Current and proposed payment policies of the Health
Care Financing Administration fail to recognize the
unique role of academic medical centers in the delivery
of health care services to Medicare beneficiaries and
threaten the financial viability of institutions and pro-
grams that serve a critical public good.
14. Each academic cardiovascular program has a critical
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and minimal patient volume that is central to its
missions, but cannot resort to historical strategies to
maintain patient referrals fundamental to its teaching
and research missions.
15. Traditional organizational schemes of academic depart-
ments have placed cardiovascular programs with less
related specialties, rather than with specialties such as
cardiovascular surgery, interventional radiology, cardio-
vascular anesthesia and pediatric cardiology.
Challenges to the Academic Cardiovascular Program
Academic medical centers have had increasing difficulty
attracting sufficient patients, particularly in areas of the
country in which managed care has achieved market dom-
inance (7). Several factors render traditionally structured
academic centers ineffective in the marketplace.
Shifting resources. The business of academic cardiovascu-
lar programs has historically relied on delivering high
quality services and a monopoly in tertiary care of complex
patients. However, they have succeeded in training out-
standing physicians who have moved into the community.
As high quality cardiovascular resources have proliferated in
the community, academic cardiovascular programs have lost
much of this traditional advantage to the community
provider.
Separation from the community. Traditional academic
cardiovascular programs have segregated themselves from
their primary care feeder stream to pursue their tertiary and
quaternary care goals and have had difficulty constructing
the provider networks that are necessary to contract under
managed care. Attempts by some academic programs to
develop their own feeder programs have further alienated
the community. The teaching model in which attending
physicians were on service for only a month or two per year
and most of the communication with referring physicians
was conducted by residents often fails to establish the
necessary relationships with community physicians that they
deserve.
Noncompetitive structure. The structure of the academic
medical center has failed to provide sufficient incentive in
patient care and tends to inhibit collaboration among
providers of related services outside the departments of
medicine/pediatrics. Cardiology divisions have often been
disproportionately viewed as the major revenue source for
departments of medicine/pediatrics. The subservience of the
cardiology division to the department of medicine often
creates disincentives against profitable initiatives and may
stymie appropriate collaboration with the hospital, with the
cardiothoracic surgery division and with community-based
physicians. There is often a lack of alignment between
departments of medicine/pediatrics and divisions of cardi-
ology, and economic structures may neither support aca-
demic cardiology nor foster profitability within divisions of
cardiology. Because procedural revenue has decreased, this
problem has become a major issue in most departments of
medicine.
Cardiology divisions at risk. With the development of
high cost procedures such as interventional cardiology, large
clinical revenues were available to support cardiology divi-
sions and departments of medicine. With the expansion of
interventional and bypass programs to community-based
hospitals, academic cardiology divisions have been placed at
risk. This has been further influenced by these community
hospitals having cardiology and interventional training pro-
grams, which increases the competition from the commu-
nity with additional available practitioners. Furthermore,
with falling reimbursements and increasing costs of these
technical innovations, it may be more cost-effective to shift
less complex procedures to the community, further reducing
revenue to the cardiology division, departments of medi-
cine/pediatrics and ultimately the academic medical center.
Changing environment. The forgiving environment of
state support and fee for service medicine has been replaced
by declining revenues, the uncertain future of managed care
and the progressive loss of government support. This
threatens not only the health but, in some cases, the survival
of academic medical centers.
Primary care emphasis. Current economic forces tend to
organize delivery of health care around primary care physi-
cians. Academic medical centers have traditionally focused
on specialty care. Patients are often channeled away from
academic medical centers in newly integrated health care
delivery systems. Building new relationships with the phy-
sicians in the region when these relationships have been
strained in the past is difficult and many times impossible,
particularly in geographic areas with heavy penetration of
managed care contracting. This problem may also exist
within an academic medical center when primary care
physicians provide an inadequate referral base for cardiovas-
cular programs.
Internal structure. Many of the challenges to academic
medical centers are internal, however, and must be solved by
the center. These include a faculty structure in which each
department functions with little accountability to the whole.
Whereas competitors have a focus on efficient health care
delivery, academic medical centers try to excel simulta-
neously in research, teaching and patient care. The impact
of this approach is substantial and it may not be tolerable.
Performance measures. In the past, academic medical
centers have considered effective management of difficult
cases as a quality indicator, whereas the managed care
industry and government define quality as adherence to
Health Plan Data and Information Set indicators. Thus,
statistical comparisons do not accurately reflect quality when
applied to tertiary and quaternary patients in academic
medical centers. This is best reflected in the number of
patients who are transferred from community hospitals and
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other tertiary care centers for high risk interventions or
surgery. This information is not available on current stan-
dard databases and underscores the importance of the
development of better measures of clinical performance and
outcomes with resultant benchmark criteria.
Teaching models/mission. Academic medical centers
have historically developed models for teaching and at-
tempted to adapt them for patient care rather than the
reverse. The structure of these services follow guidelines
imposed by residency review committees and often are ill
suited for clinical care. Placing specialty patients on general
teaching services requires an attending physician who may
not be suited to provide specialist care. The quality of
patient care can be supported by liberal use of consultants,
but precious hours and dollars are lost in the process.
Trainees in the outpatient clinic can also produce ineffi-
ciency and patient dissatisfaction if the teaching model is
not well constructed. In addition, variation in practice
patterns from one physician to another is as prevalent in
academic medical centers as in community counterparts.
Following a single care path with a new contingent of
residents each month is challenging. Furthermore, aca-
demic cardiologists are sometimes removed from more
highly remunerative activities on the cardiology services
to treat noncardiac patients on the general internal
medicine service.
Faculty expectations. Faculty members who chose aca-
demic careers in another era are often disgruntled because
the expectations have changed and their ability to meet their
career goals is threatened. Meeting the goals of the institu-
tion with people who are dissatisfied, and who often have
tenure, is a major challenge to the medical school and
therefore the academic medical center. In cardiology, tal-
ented clinicians and proceduralists are often underappreci-
ated during promotional reviews and are instead attracted to
community-based opportunities. Clinical contributions are
not measurable by classic academic scales and are not as
central to promotion as education and research contribu-
tions. Furthermore, cardiologists are often held to a pro-
ductivity standard that is different than that of other
department of medicine members. In addition, for those in
the clinical arena, tenure consideration during promotion is
often of lesser value.
Reimbursement/documentation. The future holds more
challenges. New documentation requirements of the activity
of the faculty imposed by the Health Care Financing
Administration are costly to implement. In addition,
changes in the Practice Expense component of the
Medicare fee schedule will disproportionately affect
specialty-laden faculties and especially cardiology divi-
sions. Continued pressure on reimbursement is likely,
and the appetite for cost containment of the nation has
not yet been sated.
ADVANTAGES OF ACADEMIC MEDICAL CENTERS
Despite considerable challenges confronting academic med-
ical centers in the immediate future, such centers have
unique capabilities/strategic advantages that should be used
to confront the challenges. These advantages can enhance
the opportunities for integration of research, teaching and
clinical care while providing incentives for potential rela-
tionships with community providers.
Expertise. Academic medical centers are capable of pro-
viding a broad spectrum of expertise that should provide for
unique capabilities in innovation of clinical care. Some
subspecialists may be used in the evolution of critical
pathways, product line development and restructuring of
clinical care models (8). Moreover, the depth of expertise
may make reorganization across product lines more feasible
in an academic medical center than in the traditional
context of specialty health care providers. In many locales,
academic programs offer unique expertise in high risk
angioplasty, congestive heart failure/transplantation, elec-
trophysiology, adults with congenital heart disease and
cardiac genetics.
Application of basic research to clinical practice. The
opportunities for translational research from basic science to
the bedside represent enormous growth opportunities for
academic medical centers. Indeed it is the opportunity to
link sophisticated investigator-initiated biological research
with clinical expertise that most strongly differentiates the
academic medical center from community providers and
industry. Recent basic research discoveries have led to novel
therapies that include, but are not limited to, brachytherapy
for restenosis, percutaneous transmyocardial laser revascu-
larization to stimulate angiogenesis and vascular endothelial
growth factor (VEGF) for peripheral vascular disease, and
the promise of gene transfer technology presents unique
opportunities for academic medical centers to expand their
clinical responsibilities. Alignment between industry and
academic medical centers in translational research provides
enhanced opportunities for academic medical centers to
market themselves as the providers of true quaternary care to
a knowledgeable and discerning patient population. More-
over, the American patient population continues to demand
access to specialists who are capable of the most sophisti-
cated medical care. The alignment of the academic medical
center to industry represents an important strategic advan-
tage in this regard.
The academic medical center needs to be more aggressive
at protecting and developing the intellectual property of its
faculty. This will clearly be a source of future revenue during
this time of rapid growth in biomedical and genetic engi-
neering. If patents can be licensed to companies in the same
geographic region as the academic medical center, that can
be of benefit to the local community. If faculty are encour-
aged to develop companies so that patents they develop can
be licensed back to faculty companies, additional methods
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will be created to fund research as well as maintain faculty in
the academic medical center.
Academic medical centers that have successfully part-
nered with community physicians possess a unique oppor-
tunity to enroll large numbers of patients in industry-
sponsored trials. Academic medical centers often possess the
opinion leaders who provide the impetus to these trials, and
whose participation in the design, implementation and data
analysis of these trials is of importance. Better marketing of
these two advantages by the academic medical center to
industry can also serve as a revenue source in the future.
However, when industry is the initiator of new drugs,
biologics or devices, the academic medical center is often
not the partner they currently seek for initial patient trials.
Recognized expertise is in the community, the overhead
costs are often lower and bureaucratic obstacles are typically
less burdensome. The academic cardiology division cannot
afford to surrender this traditional relationship with industry
and must continue to compete for clinical studies generated
from basic science work performed in industry.
Organizational structure. The organizational structure of
academic medical centers might suggest that there can be a
closer alignment of purpose between faculty, hospital and
medical school than in the community hospital with com-
munity specialists. This potential alignment is not often
strategically explored, as traditional agendas have been
perpetuated.
Administrative structure. An important advantage of the
academic cardiology program is that the practitioners within
the academic medical center have defined leadership and are
used by a single entity. This structure is in marked contrast
to nonacademic medical centers that must contend with
multiple group practices and which often have unwieldy
bylaws requiring a majority vote to enact any new practice
patterns or to establish contractual relationships with insur-
ers. Furthermore, it provides a mechanism by which physi-
cians can be given incentive to maintain a relatively consis-
tent practice pattern and to comply with new practice
guidelines.
Brand equity. The American population will continue to
demand access to specialty care. This is manifest by point-
of-service options, plateau enrollment in heavily controlled
managed care plans and continued requests for subspecialty
services. The brand equity that academic medical centers
bring to specialty care has not been sufficiently exploited by
many centers. Patients will never want to be excluded from
the “court of last resort,” and academic medical centers are
in the unique position of providing such quaternary care. In
addition, evidence of patient concern about not being able
to choose their own physicians is responsible for the
negative backlash against Health Maintenance Organiza-
tions appearing in recent U.S. congressional campaigns.
Information systems. Whatever occurs in the evolution of
American medicine, information system capabilities will be
central to the long-term success of health care providers.
The integration of information systems with clinical care,
medical management and any prospective payment system
will occur. Academic medical centers may be in the unique
position to take a leadership role in the evolution of such
information systems that integrates inpatient and outpatient
activity and larger system approaches. In the short term,
community providers may have more relevant information
systems that address their day-to-day needs. The academic
medical center also has had a traditional mission to provide
access to computerized reference services and innovative
educational material, but the widespread availability of
Internet services has deeply discounted this traditional role.
POTENTIAL SOLUTIONS/OPPORTUNITIES
Academic medical centers are poised to redefine their
relationships with the community and the departments of
medicine/pediatrics in a fashion that can be instrumental to
their long-term viability (6,9–11). Geographic differences
and rapidly moving market forces make a standardized
approach impossible, but a number of different strategies
have already proven to be successful. Whatever solution or
opportunity is identified, academic medical centers must be
proactive in its initiation.
External Relationships
Acquire primary care practices. The acquisition of pri-
mary care practices has clearly channeled specialty care to a
number of academic medical centers. This has allowed them
to maintain a high census during times of declining specialty
care needs. However, such acquisitions have been a financial
burden, and are now being reconsidered by a number of
integrated health care systems. Moreover, shifting an ac-
quired practitioner from a private practice model to a staff
model for remuneration purposes has consistently resulted
in reduced provider productivity. Academic cardiovascular
programs have benefited from these department/
institutional initiatives, but should not rely on them as their
sole future strategy.
Develop primary care networks. Although such networks
have usually been directed toward the development of a
system capable of accepting large managed care contracts,
their intended consequence has also been to rechannel
specialty care to the academic medical center associated with
such networks. Moreover, the investment in the infrastruc-
ture of such networks has primarily benefited the primary
care physicians and only indirectly the specialists.
Subspecialty care clinics/outreach programs. Establish-
ing subspecialty clinics in conjunction with community
physicians has been welcome in many regions. Although
some community specialists will certainly view this as direct
competition, the ability of academic specialists to work
closely with community physicians will often be perceived as
enhancing the capabilities of community physicians. The
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academic medical center benefits because new sources of
potential patient referrals are created. These relationships
can often be established based on “goodwill” without formal
contracts. This is in keeping with traditional referral pat-
terns that are based on mutual respect and personal rela-
tionships and not exclusive contracts. However, it is impor-
tant to note that one means of changing referral patterns is
providing financial incentive. Moreover, inviting commu-
nity specialists to participate in other missions of the
academic medical center (teaching, clinical research proto-
cols) serves to enhance their participation/affiliation/
allegiance to the long-term mission of academic medical
centers.
Partnering of community hospitals and academic special-
ists serves a similar need. This outreach provides community
hospitals with sub-subspecialty care that might not other-
wise be available to them.
Subspecialty carve outs. There are a number of potential
carve-outs that may emerge in managed care for subspe-
cialty care and will depend upon the degree of managed care
penetration. Such carve-outs might include diabetes, hyper-
tension, end-stage renal disease and congestive heart failure.
They offer the ability of an academic cardiovascular program
to offer cardiology capitated carve-out products as managed
care evolves. This model requires the ability to offer regional
cardiology services, which can be capitalized by the large
academic medical center, and provides high quality practi-
tioners for managed care providers. It also potentially
provides for cost saving, since a single employer is identified
so practice patterns can be uniform and respond quickly to
the rapidly changing environment of health care reform.
Additional cost savings can also be realized because this
model allows shifting of procedures such as stress tests,
echocardiograms and diagnostic catheterization to commu-
nity hospitals where they may be able to be performed at
lower costs, while shifting more complex procedures to the
academic medical center, fostering mutual benefit. Such
carve-outs by definition require a broad geographic distri-
bution of academic center–related cardiologists and are an
important outgrowth of long-term specialty outreach strat-
egies.
Leasing arrangements. Full-time interventional faculty or
sub-subspecialists in the academic division of cardiology are
leased to community clinical cardiologists who wish an
affiliation with the academic medical center but do not wish
to be purchased. The community cardiologist pays a portion
of the academic salary and in exchange, the academic
clinician/interventionalist receives patients for interven-
tional procedures or clinical care. The academic medical
center gains new referrals and associated referrals to other
cardiology services while the patient is in hospital. The
community cardiologist can then legally receive part of the
professional fees from the interventions or other procedures
performed, since the academic cardiologist is a part-time
employee of the community practice.
Purchase of cardiology practices. Due to falling reim-
bursements and excessive numbers of cardiologists in the
community, high quality community cardiologists may con-
sider being purchased by academic medical centers. In
exchange, they expect regional exclusivity within the aca-
demic cardiology network and full membership in any
network products. They are also provided with long-term
contracts with minimum salary guarantees. Once purchased,
these groups include the academic center as a site for
interventional procedures. Because most academic medical
centers expect minimal numbers of interventional proce-
dures to be performed in their facilities, these purchases
increase the academic centers’ interventional patient vol-
umes and associated inpatient admissions. Once these
physicians develop relationships with other academic spe-
cialists including electrophysiology or congestive heart fail-
ure/transplantation, additional referrals to the academic
medical center may occur. However, preexisting referral
patterns may abrogate the ability of purchased practitioners
to move their cases to the academic center if the groups
referring primary care physicians demand that their patients
remain at the nonacademic medical center.
Internal Restructuring
The future success of the academic cardiovascular division
depends on its ability to leverage a number of the potential
market advantages that it possesses in a business-like fash-
ion to maximize their impact. These include:
Broad clinical strength. Community hospitals often pos-
sess cardiologists with skill and technical expertise equal to
the faculty in academic divisions. However, academic pro-
grams often have greater breadth of expertise with sub-
subspecialists in congenital heart disease in the adult,
electrophysiology, congestive heart failure/transplantation
and outcomes analysis.
Align incentives. The academic medical center should
foster an environment that is conducive to alignment of
incentives among physician groups (e.g., cardiology and
cardiothoracic surgery divisions) and between physicians
and hospitals. Such alignment may be instrumental in
augmenting revenue and managing down institutional costs
to maximize profitability of the entire system. These
factors—academically credible clinical strengths and an
environment conducive to aligning incentives—are often
not adequately leveraged by academic centers, in large part
because of bureaucratic obstacles, a lack of mutual trust
among the various parties and fear, on the part of depart-
ments of medicine/pediatrics, of losing control.
Become cost-competitive. It is imperative for survival that
academic medical centers provide care at costs that are
competitive with surrounding community hospitals. The
academic medical center faces this challenge with a number
of intrinsic disadvantages and some advantages which have
not been adequately developed and deployed. In many
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instances the faculty practice only at the academic hospital,
and practice at the academic hospital is dominated by
faculty members. This facilitates aligning financial incen-
tives to reduce cost. When patients’ length of stay is
reduced, the reimbursement to the physician correspond-
ingly drops. But the physician effort required to produce the
shortened length of stay may increase. If physician and
hospital incentives are allowed to conflict, improvement in
performance can be achieved only by imposition of rules,
guidelines and threats; and success will be limited. In
creating a funds flow process in which the academic depart-
ments benefit as the hospital thrives it becomes possible for
the faculty member to provide the extra effort required for
good fiscal results. Because the faculty may be employees of
the health system, novel financial arrangements may be
constructed between the hospital and the academic practi-
tioner. Cost-competitive care can be delivered by other
means; the academic medical center is an ideal environment
to standardize purchasing and inventory items; physician
involvement can produce substantial savings through bulk
purchases of high-end technical equipment.
Minimize variation in practice patterns. Variation in
practice patterns increases cost of medical care without
measurable influence on quality. Although one can argue
which group of physicians is offering procedures at the
“correct” frequency, there is rarely evidence that the general
health of the population treated with the higher number of
procedures is better. Academic medical centers might prefer
to consider their practices evidence-based, but this may not
always be the case. The same clinical history, stress test
result and stenosis identified by coronary angiography may
trigger variations in coronary intervention or medical ther-
apy.
The value of variation in patterns of acceptable practices
must also be readdressed. The educational mission tradi-
tionally requires proof that more than one direction of care
is acceptable. A standard approach to care may reduce
inventory costs and provide routines that allow nursing and
technical personnel to become very skilled and efficient in
providing care. However, such an approach is viewed by
many as antithetical to the academic environment in which
the trainee is traditionally thought to benefit by observing
multiple paths to the same end. The trainee is considered to
be in a better position to judge the best way after this varied
experience. This precept must be reconsidered, for this
educational approach is prohibitively expensive and scien-
tifically flawed. To propose that the educational “best way”
can be determined by a trainee based on uncontrolled
experiments in which patients vary, entry criteria are not
defined and end points often are not collected or analyzed
except in an anecdotal fashion is inconsistent with our
collective scientific heritage.
Define training/workforce. Unlike our colleagues in many
of the surgical subspecialties, adult cardiologists have failed
to limit the number of physicians that are trained in
cardiovascular disease each year. Legal concerns about
restraint of trade are usually articulated as justification for
lack of action. This fact, more so than any other, has
negatively affected the economics of cardiovascular care in
the U.S. and might well contribute to the actual or perceived
overuse of cardiovascular services in many geographic re-
gions. Although many academic cardiovascular programs
have substantially restricted the number of fellows that are
enrolled each year in their cardiovascular training programs,
nonacademically affiliated and smaller training programs
have failed to alter their enrollments. In fact, any reduction
in the smaller training programs threatens their viability
with regulatory bodies and the institutional purpose that
they serve. Furthermore, many of these community-based
training programs barely meet or fail to meet the basic
requirements provided by the American College of Cardi-
ology. Their clinical volume often precludes adequate train-
ing in sub-subspecialty areas, including electrophysiology,
preventive cardiology, heart failure and cardiac transplanta-
tion and adequate six-month research experience resulting
in scholarly publications. Although there are many examples
of excellent non–university-affiliated programs that meet
these requirements, many more cannot. Since such training
is a requirement of certification, it is imperative that the
academic cardiovascular programs, the American College of
Cardiology and the Accreditation Council for Graduate
Medical Education address this issue.
Nonphysician extenders. Academic cardiovascular pro-
grams have often been slow to optimize the value of
physician extenders to improve efficiency of clinical care.
Residents and fellows are traditionally integrated into the
continuum of clinical care as part of the teaching mission,
whereas community providers have markedly improved
their efficiency with nurse practitioners, clinical nurse spe-
cialists or physician’s assistants. It now becomes a challenge
to the academic program to incorporate these valued non-
physician colleagues in a fashion that compliments the
educational mission.
Advocate change in payment policies of the Health Care
Financing Administration. Current and proposed pay-
ment policies of the Health Care Financing Administration
should be revised to diminish their adverse effects on clinical
practice at academic medical centers. Specifically, the poli-
cies should:
● Recognize uncompensated care as a legitimate physician
practice expense.
● Provide adjustments to the outpatient prospective pay-
ment system to recognize the added costs of teaching and
providing care to populations with a disproportionate
share of Medicaid recipients.
● Extend the exception for teaching physician supervision
of residents to all specialties that provide evaluation and
management services.
● Provide payment to teaching physicians for the services of
1104 DeMots and Mudge JACC Vol. 33, No. 5, 1999
Task Force 1: Clinical Care April 1999:1091–135
medical students provided under direct physician super-
vision.
● Reduce the physician presence requirements of the teach-
ing physician rules for private practitioners willing to
teach residents in their offices.
● Provide adequate payment to support the care of children
and adults with congenial heart defects.
Any future discussion of payment of graduate medical
education by payers other than Medicare should recognize
that the current level of funding may be inadequate. In other
words, some of the contributions to the funding of graduate
medical education by payers other than Medicare should be
in addition to, not as a substitute for Medicare funding.
Relationship between the academic cardiovascular divi-
sion and the departments of medicine/pediatrics. The
academic mission of the departments of medicine/pediatrics
is essential, but academic cardiology programs have a
traditional relationship with their department of medicine
that needs to be reexamined. Although the departments of
medicine/pediatrics continue to be central for academic
recruitment and credentialing, there are other constituents
and partners for the academic cardiovascular programs,
which include hospital leadership and integrated networks
among others, whose needs must be addressed. A restruc-
tured academic cardiovascular division will ultimately be of
more benefit to a department and its other subspecialty
divisions than the current fragmented approach.
The present alignment of the various subspecialties into
departments of medicine, pediatrics, surgery and obstetrics
and gynecology dates back to the late 1800s, a time when
cardiologists’ primary tools were their hands and their
stethoscopes. However, like all of medicine, the practice of
cardiology has changed dramatically. Indeed, cardiologists
are sub-subspecialized with independent board certification
in at least two of these highly specialized areas, electrophys-
iology and interventional cardiology. Furthermore, the pri-
mary point of service is more often an interventional
laboratory than an outpatient clinic, and the practice of
cardiology has far more in common both intellectually and
technically with the surgical subspecialties than with tradi-
tional medical subspecialties. Despite these differences,
cardiology divisions are still expected to support less remu-
nerative divisions of the departments of medicine/pediatrics,
and meet more robust productivity standards. However, this
disparity is far from novel. Over the past several decades,
similar disparities existed between the goals of the surgical
subspecialties and those of the department of surgery,
resulting in the development of departments of otorhino-
laryngology, neurosurgery and cardiothoracic surgery. Even
in schools of medicine, divisions of neurology and derma-
tology have become independent departments. However,
perhaps the most relevant models for the cardiology pro-
grams of the future are the 50 centers of excellence in
oncologic disease that have been developed at academic
centers across the U.S. These centers of excellence, funded
both privately and publicly, have had substantive effects on
the care of patients with malignancies and have provided
multidisciplinary and collaborative centers allowing for out-
standing levels of patient care, rapid transition of new
technology to the patient and interdisciplinary collaborative
research. These stand-alone facilities compete effectively for
patients with community hospitals and practitioners and in
some ways exist as economically independent entities. By
having administrative responsibilities to a larger health
system, they are able to bypass much of the academic
bureaucracy that has slowed the ability of these academic
divisions to respond to change.
A number of different and successful models should be
considered by the academic cardiology division. Cardiovas-
cular specialists at the Washington Hospital Center have
developed a superb organization structure for cardiovascular
care outside the traditional department of medicine. Their
clinical trials in interventional cardiology are leadership
investigations, their commitment to basic research is ex-
panding and their outreach/merger with other institutions
or individuals makes them competitive with the most
prestigious institutions in the mid-Atlantic States. In other
regions, for-profit ventures in cardiac catheterization have
proven to be fiscally sound and serve as an example to
academic cardiology programs for their efficient business-
like clinical care.
Several cardiovascular centers have been successfully in-
tegrated into the academic mission of their respective
institutions; Mount Sinai Medical Center’s Cardiovascular
Institute and the Cardiovascular Institute at the University
of Pittsburgh Medical Center are perhaps the most com-
pelling current examples. Common characteristics of these
efforts include advisory boards responsive to the governing
health care system, horizontal multidisciplinary integration
across clinical care and all research endeavors and indepen-
dence from their traditional departments to forge new
community relationships and to develop marketing and
philanthropic strategies while maintaining fiscal responsi-
bilities to and academic credentialing by their respective
departments and medical school.
OPERATIONAL CHANGES
There are a number of operational changes that might be
considered by academic cardiovascular programs.
Hospitalists
The evolution of hospitalists may in fact improve the
efficiency and use of patient resources. Full-time individuals
committed to inpatient care should result in reduced length
of stay and hospital costs. However, the evolution of
academic hospitalists will require substantial restructuring of
traditional academic/clinical roles. The early involvement of
an attending physician who can direct care in a way that
moves the diagnostic workup in the most expeditious
manner, and institutes therapy and discharges the patient at
1105JACC Vol. 33, No. 5, 1999 DeMots and Mudge
April 1999:1091–135 Task Force 1: Clinical Care
the earliest reasonable moment is essential. This requires
that alternative strategies must be created for training
programs which benefit from a more leisurely hospital
course.
Academic medical centers can provide care with low
mortality and with acceptable lengths of stay when consid-
eration is given to the severity of illness found in patients at
an academic medical center (12). In many instances the
costs of this care are still higher than in the community.
These higher costs could be due to higher utilization or
other inefficiencies or cost shifting from the educational
mission and from the care of indigent patients. To the
extent that they are the former they must be addressed.
Advantages of a Product Line Structure
Restructuring the delivery of cardiovascular services into a
“product line” consistent with its academic mission and
goals represents one mechanism for advancing the academic
cardiovascular division toward a more competitive position.
Furthermore, product line development links cardiologists
with the most appropriate academic colleagues: those spe-
cializing in cardiothoracic surgery, pediatrics, interventional
radiology and cardiac anesthesia. Such a structure might
have the following characteristics and advantages:
1. Strengthened fiscal and operational ties among physician
groups that provide related clinical service, in a structure
that provides incentive for revenue-seeking and cost-
cutting behavior.
2. Alignment of incentives between hospital and physi-
cians.
3. Facilitation of initiatives toward maximizing quality
while minimizing cost.
4. Facilitation of specialty-oriented risk contracting, serving
to network the academic cardiovascular division and
community providers by adding value through initiatives
to a) reduce cost internally and b) implement medical
and disease management programs system-wide.
5. Increased use of clinical care teams, including nonphy-
sician health care extenders.
Product Standardization
Product standardization is difficult to implement, because
specialists tend to cling to their favorite device or imple-
ment. In many instances the faculty members may have
participated in the development of a device or performed
crucial research to validate or improve a device or drug.
When a hospital is forced to stock numerous brands of the
same device it raises inventory costs for the hospital and it
prevents the hospital from participating fully in volume
discounts or in buying consortia that reduce costs. Academic
cardiologists will be faced by requests from hospital admin-
istrators to use predominately a single brand of pacemaker,
defibrillator or angioplasty catheter to offer their services to
an adequate volume of patients. In some instances their
choices will be limited by a buying consortium that is
remote from the institution. Therefore, regular meetings of
a group of cardiologists to present patient cases for discus-
sion to develop common practice patterns will be of impor-
tance. An example would be weekly conferences for the
interventionalists in the catheterization laboratory. They
may decide to develop consistent strategies for a given
stenosis morphology, a specified IIb-IIIa antagonist only for
angiographically identifiable clot, and they may choose a
single “workhorse” balloon (from a single vendor) for the
most straightforward stenoses. Such an approach is prefer-
able to having such decisions imposed by a hospital admin-
istrator and can drive down operational expenses.
Clinical Pathways
Practice patterns can be standardized by using clinical
pathways, practice guidelines and algorithms. The design
and implementation of these tools is difficult and time-
consuming but, if properly performed, can produce im-
provements in outcomes and reduction of cost. Resistance is
often encountered by condemning these efforts as “cook-
book medicine.” They should never be used as an excuse for
failing to meet the special needs of a patient or providing
appropriate variation in care when the clinical situation
demands it. Appropriate use, however, provides reminders
for the implementation of care, a time-conserving set of
standard orders that can be modified to fit the clinical
situation and a template from which variation can be
recorded. The greatest value of pathway development may
accrue from the act of development in which experts and
other providers come together to research current practice
patterns in the hospital and agree on a uniform approach
based on best evidence. Usually these groups can agree on a
best approach, but when legitimate disagreements occur it
provides a basis to compare the financial and clinical
outcomes of patients treated in different ways.
In cardiology there are a number of conditions that are
suitable for pathway development such as chest pain, myo-
cardial infarction, pacer implantation or pulse generator
change and coronary angiography for stable angina. Other
conditions such as congestive heart failure will be more
difficult, because the clinical course of a patient may be
driven by a number of comorbidities that are found in these
patients. In many complex conditions found in an academic
medical center the best guidance may come from practice
guidelines or algorithms which apply branching logic at key
decision points rather than the linear course provided by a
clinical pathway.
Communication of the pathways and guidelines is a
challenge for academic medical centers because of the
inclusion of fellows and residents in the care model. Geo-
graphical concentration of like patients allows nurses to
become important promoters and educators of the residents
in standard procedures. Storing materials on easily accessi-
ble and user-friendly electronic media or web pages com-
plete with references, tables, diagrams and preprinted orders
promotes use of the path and offers an educational resource
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for the trainee. Limiting the number of faculty attending
physicians to a small expert group who perform attending
tasks regularly rather than assigning the attending task to a
large group for one month per year favors standardization of
practice and use of these tools. Finally, the use of “hospi-
talists” and physician extenders will also be important for
accomplishing these goals.
Redesign Teaching Models
None of these efforts will be successful in producing the
required results if the teaching model that has been used for
decades continues without modification. In its most extreme
form residents were permitted to evaluate and treat the
patient with input sometime during the course of the
admission from an attending physician who concentrated on
the interesting pathophysiologic mechanisms and left the
details of care to the residents. In many instances decisions
with major cost implications have been made before the
attending physician intervenes. The resident, who feels
more pressure to be complete than to be cost-effective,
orders more tests than necessary and relies on the laboratory
examination rather than the history and physical examina-
tion to establish the diagnosis.
Whenever possible the attending physician must be
expert in caring for the condition with which the patient
presents. Relying on consultations in an academic medical
center predisposes to the use of more resources and longer
lengths of stay. Residency review committees which favor
general wards for medical patients rather than specialty
wards should reexamine their position. Patients whose
reason for admission is cardiovascular disease should be
cared for by cardiologists and patients with other illnesses
should not be cared for by cardiologists in the academic
setting, nor should cardiologists carry teaching responsibil-
ities on noncardiovascular services.
Trainees are not and should not be faced with the primary
responsibility of maintaining the fiscal integrity of the
academic medical center. They should, however, be taught
to practice medicine in a cost-effective manner, for that will
be their obligation for the remainder of their careers. It is
the obligation of their teachers to provide this education.
Most important, many referring physicians want to com-
municate exclusively with the attending subspecialist and
not with trainees. The commitment of the academic faculty
to excellence in all the nuances of effective clinical care and
communication must be identical to their commitment to
excellence in research.
Disease Management
Disease management and medical management services:
rationale. The future viability and competitiveness of aca-
demic cardiovascular divisions will depend on offering value
to the community, particularly as services continue to shift
to the community and community-based cardiologists as-
sume more and more of the financial risk for health care.
Academic cardiovascular divisions continue to have unique
expertise, facilities and stature that place them in an
excellent position to add value through development and
implementation of disease management and medical man-
agement services.
Medical management is an interactive process through
which a medical manager interfaces with clinicians provid-
ing care, reviews the medical advisability and necessity of
anticipated services, screens for service duplication and
offers cost-effective alternatives. It has proven highly effec-
tive in reducing health care costs, but requires sophisticated
information networking and processing. Disease manage-
ment is a methodology designed to increase cost-
effectiveness of care associated with a specific disease entity.
There is a substantial opportunity to network with
community providers by offering subspecialty risk carve outs
to primary care providers receiving capitation. Academically
based cardiologists can offer such carve outs alone or in
collaboration with community-based cardiologists. Medical
management and disease management programs represent
the principal strategies through which academic programs
can help to manage down the cost for the community
provider, while maintaining or improving quality of care.
Vying for the delivery of disease management services.
The academic medical center will be competing with a
number of different contenders vying for the delivery of
disease management services. These include commercial
vendors, Health Maintenance Organizations, nonacademic
and for-profit delivery systems and community-based man-
agement services organizations. The academic delivery sys-
tem is in an excellent position to compete for delivery of
disease management services, if it can a) leverage the
expertise of its specialty services, particularly cardiology and
b) forge the proper relationship with community-based
providers.
The expertise and credibility of academic cardiovascular
divisions create an immediate advantage over commercial
vendors in the development and delivery of disease man-
agement services. Furthermore, the academic cardiovascular
division need not make an immediate direct profit on the
disease management services that it develops. Rather, it can:
a) leverage the value of the product toward network devel-
opment and b) derive value in the long term through
managing down the costs of its own patients and those of its
networked community physicians. Therefore, in contrast to
commercial vendors, the academic cardiovascular division is
positioned to deliver a less costly and more cost-effective
product.
The challenge is for the academic medical center and the
academic cardiovascular division to overcome the obstacles
that impede them from benefiting from their natural ad-
vantages. These obstacles include the sluggish, unresponsive
nature of the typical academic bureaucracy and reluctance to
invest without demonstrable short-term gain. It is essential
for the leadership of academic cardiovascular divisions to
meet this challenge.
1107JACC Vol. 33, No. 5, 1999 DeMots and Mudge
April 1999:1091–135 Task Force 1: Clinical Care
Marketing Strategies of Academic Medical Centers
Academic medical centers are in a unique position to
develop and enhance their capabilities in conventional
marketing strategies. A marketing and planning department
of an academic medical center may be an integral part of its
success. This will contribute to an understanding of the
marketplace and marketplace issues, and represents an
opportunity to study, and then shift market share into
academic programs.
Although contrary to the original purpose of academic
medical centers, the marketing department of an academic
medical center brings a new perspective to its mission by
focusing on activities which reflect priorities and strengths,
building value and loyalty among target markets. In such
marketing efforts, the image of quality and integrity can be
maintained, supporting the role of the academic medical
center. Such marketing activity can include:
● Market analysis and market research, to make customized
market information available to administrative and clini-
cal management.
● Development of regular reports on referring physician
information, by demographics, number of referrals and so
forth.
● Addressing the responsiveness of academic medical cen-
ters to customer preferences by internal reorganization,
improving the often unfriendly customer service attitudes
that prevail within academic medical centers in respond-
ing to referring physicians’ needs.
Telemedicine
An academic marketing and planning commitment also
entails a commitment to the evolution of telemedicine.
Telemedicine capabilities expand the access of academic
medical centers to referring physicians and consumers.
Interactive marketing techniques, including the Internet,
CD and telemedicine capabilities, represent unique oppor-
tunities for academic medical centers in the future.
CONCLUSIONS
The preceding discussions demonstrate the importance of
subspecialization within the academic division to enhance
cost-effectiveness and to strengthen unique aspects of the
academic division which distinguish it from community
providers. Future strategies cannot be based on surrender of
the clinical mission to community cardiologists but rather a
closer collaborative relationship with them. The future
academic division should not be a small core of academic
physicians involved in basic research or outcomes research
solely on the patients of community cardiologists. Rather,
its future should be based upon strengthening the subspe-
cialization within cardiology, so that the academic division
continues to provide a unique expertise across all disciplines
in cardiology which is not widely available in the commu-
nity. This model is based on continuing the tradition of the
academic clinician, through patient care, identifying impor-
tant areas for future investigation, education and continuing
to provide leadership for the direction of both basic and
clinical research. However, this approach also recognizes
that the era of “triple threat,” the academician capable of
performing successful patient care, research and teaching
emulated in the past, is no longer a part of a viable academic
model.
Academic cardiology divisions must be proactive in rede-
signing their purpose and relationship to other providers to
maintain traditional missions. This restructuring should
ultimately benefit all health care providers and improve
access of all patients to the best cardiovascular care.
RECOMMENDATIONS
● To sustain and expand their commitment to patient care,
teaching and basic and clinical research, academic cardio-
vascular programs must respond to the revolutionary
changes in health care by restructuring external relation-
ships and redesigning their internal organization.
● Academic cardiovascular programs should redraw their
conventional boundaries by the development of collabo-
rative relationships with a broad base of practitioners and
hospitals for advancing clinical care, promoting clinical
research and fostering more comprehensive teaching of all
health care professionals.
● Academic cardiovascular programs should approach their
long-term mission in a more business-like fashion. Incen-
tives must be aligned, cost-competitive measures insti-
tuted and variation in practice patterns reassessed.
● Academic cardiovascular programs should reexamine
their traditional relationships to respective departments of
medicine or pediatrics. Reorganization of clinical, re-
search and teaching commitments with related specialties
in other departments may ultimately enhance the success
of all participants in the academic health center and
improve the access of patients to the best cardiovascular
care and research ideas.
● Academic cardiovascular programs should promote their
unique capabilities in clinical care, disease management,
outcomes analysis and clinical and translational research
to a broader constituent base of both patients and pro-
viders.
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Task Force 2: Research
Jeffrey S. Borer, MD, FACC, Co-Chair, Robert A. Vogel, MD, FACC, Co-Chair
EFFECT OF CURRENT NATIONAL MEDICAL
PRIORITIES AND REIMBURSEMENT
STRATEGIES ON CARDIOVASCULAR RESEARCH
ACTIVITIES IN ACADEMIC MEDICAL CENTERS
Scope of the Problem
The value of academic cardiological research. During the
past 40 years, management of patients with cardiovascular
diseases has changed dramatically, and primary prevention
of disease has emerged as a practical reality. Extraordinary
benefits in length and quality of human life have resulted.
The primary reason for these developments has been the
body of new knowledge created by a sustained research
effort marked by both its quantity and its quality. The
research has resulted from a partnership between academic
(medical school–affiliated teaching centers) and nonaca-
demic medical centers, industry and government in which
the academic centers traditionally have played a leading role.
Current national medical priorities and reimbursement
strategies threaten the potential for similar efforts by aca-
demic centers in the future and, thus, threaten the produc-
tive relation between medical centers, industry and govern-
ment. Specifically, the ongoing reorganization of delivery
and funding of medical services and funding of research
jeopardizes the development and even the existence of the
clinician–investigator, the clinically trained and clinically
active physician who is centrally involved in shaping re-
search goals and effecting research projects. In the past,
development of the clinician–investigator has been a pri-
mary contribution of the academic medical center. Resolu-
tion of this issue, with survival of the clinician–investigator,
is critical to continuing reduction of the burden of cardio-
vascular diseases in our society. To understand the value of
the academic medical center in cardiovascular research it is
necessary to define research, the processes it entails and the
research products of academic centers in the recent past.
Within the scientific community, research is a formal
discipline for creation of new knowledge. The process
involves application of the scientific method (hypothesis
generation and formal hypothesis testing according to long-
accepted principles for this purpose) to the solution of
problems and questions, using prespecified methods which
are ethically justifiable. The product of research is the
scientific paper; research is not complete until it has been
reported to the scientific community in sufficient detail so
that it can be replicated, criticized and, in the case of
biomedical research, applied in a process aimed to benefit
society (1).
The foregoing definition implies a degree of rigor which
generally is employed by those with formal research train-
ing. Many academic cardiologists (i.e., those who are
employed by a medical school and who are responsible for
teaching), particularly those who have earned a PhD as well
as an MD, have undergone such training and embrace
research as defined above. However, as discussed below,
formal training in the principles of research is not necessar-
ily integrated into the medical school curriculum, nor is it a
part of most cardiology fellowship training programs.
Rather, for most cardiologists, research training occurs
during an apprenticeship under a mentor, and instruction in
the formal principles of the discipline may be lacking. Thus,
many cardiologists, particularly those without formal re-
search training and those involved solely in clinical care,
may be relatively unfamiliar with the definition of research
as stated above, and with operational principles which the
definition entails.
For society at large, understanding of the definition and
methods of scientific biomedical research varies according to
individual background. However, even among well educated
persons, the concept of research generally is understood as
information gathering. The concept does not necessarily
encompass the process and, particularly, the rigor required
for proof of conclusions by the trained and experienced
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researcher. This difference in the perception of research
partially accounts, for example, for the public (and profes-
sional) outcry when drugs are not approved on the basis of
observational or uncontrolled data. The public perceives
research quantity to be “very large” in the U.S., a perception
fed by National Institutes of Health budgets of many
millions of tax dollars as quoted in the public press. In
general, the public perceives research quality to be very high,
as well; indeed, though it is seldom the focus of intense
consideration, the current generation believes that research
“will find the answers” and has difficulty understanding why
“they haven’t found the answer to that [problem] yet.”
Perceptions have changed during the past decade, most
particularly because of the proliferation of communications
technologies. These have enabled increasingly detailed and
focused questioning of the scientific community by the
nonscientific community. The result has been expanding
public awareness and sophistication and a growing need by
scientists to justify the use of public money for scientific
research (and, as a corollary, the increasing need to develop
measurement tools to define the research product). The
major influence on public perception is the public press,
including all mass media. Academic researchers can influ-
ence these perceptions (indeed, they are the source for much
reporting). However, access to mass media is limited for
academic cardiologists and varies regionally. Sophistication
in the means of effective communication by academics to
the nonscientific audience similarly varies and, as a result,
complex and important issues often are oversimplified,
leading to unrealistic public expectations and mispercep-
tions. Thus, there is great potential for public education by
the academic medical center.
In each major area of cardiovascular disease, including
coronary artery disease (chronic stable, acute), hypertension
and congestive heart failure and its many causes (including
ischemic, hypertensive, valvular and cardiomyopathic), ex-
traordinary benefits have resulted from research performed
largely in academic medical centers and involving clinician–
investigators, often as part of multidisciplinary teams fos-
tered and nurtured within such centers. A few examples
should suffice for illustration. Within the past 25 years, basic
science interdisciplinary research resolved the hepatic met-
abolic pathways responsible for endogenous cholesterol
biosynthesis. This discovery enabled cardiologist–basic sci-
entists to develop pathway-specific pharmacologic inhibi-
tors of the synthetic reaction. Ten years ago, other clinician–
investigators demonstrated the natural history-improving
benefits of applying the new therapy in practice; currently,
clinical trials are actively extending the envelope within
which net benefits can be expected from treatment. The
result has been major event reduction associated with our
society’s primary cause of “premature” death. Currently,
among patients with known coronary artery disease, approx-
imately six lives per thousand can be saved each year by
application of the results of this research (2).
Perhaps the most dramatic developments have been in
the area of heart failure, a condition which affects almost
5,000,000 people in the U.S., with an increase of approxi-
mately 500,000 new cases each year. Preclinical and basic
science studies of angiotensin-converting enzyme inhibitors
in heart failure, led and largely performed by clinician–
investigators, quickly were followed by clinical trials which
have revolutionized the treatment of this important cause of
morbidity and mortality. By extrapolation from published
data, application of this research can be expected to prolong
life by at least 1 year, beyond that otherwise anticipated, for
up to 300 of every 1,000 patients with heart failure (3).
More recent research, again featuring clinician–investigators
in the creation of concepts and shaping of objectives, has
begun assessment of molecular therapy for this condition,
promising added benefit (4). Indeed, application of the
methods of molecular biology in cardiovascular research has
been growing rapidly, and promises extraordinary future
health benefits. Contributions to the latter process have
come from both the academic and industrial sectors in
newly evolving partnership relations. However, the clinician
investigator, the product of the academic medical center,
again has assumed a critical role in shaping this application
of forward-looking technology.
Comparison of the performance of academic cardiology
with that of other research sectors is difficult. Currently,
private research entities, though increasing rapidly (see
below), are relatively small and few in number and, thus,
cannot be compared effectively with the large, heteroge-
neous entity that is academic cardiology. Industrial biomed-
ical research primarily occurs in the pharmaceutical and
devices industries. This activity is not directly comparable to
that of academic cardiology because, driven by economic
necessity, industrial research is, by definition, applied. Ac-
ademic and industrial research areas are complementary.
Therefore, even in the area of drug discovery at the basic
science level, industrial research largely is generated in
response to the fundamental pathophysiologic discoveries
which result most commonly from research in academic
medical centers. Industrial drug discovery, in turn, can
stimulate and enable further pathophysiologic understand-
ing, commonly achieved by applying the existing machinery
of academic cardiology with industrial grant funding. Sim-
ilarly, although preclinical drug/device testing can occur in
industrial laboratories, much also is performed under con-
tract by academic centers which have developed the relevant
expertise for multiple purposes. Finally, clinical testing of
drugs and devices requires effective study design and a cadre
of patients, testing physicians and enabling facilities which
already exist within the context of academic cardiology and
would be expensive to fully duplicate for industrial purposes
(although, as noted in several sections below, inroads into
the position of academic centers are being made even in this
area). A symbiotic relation exists in which academic re-
sources and expertise are harnessed in perfecting study
design and recruiting, testing and caring for patients in the
context of therapy assessment. However, as noted below,
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the growing inefficiency of the academic medical center in
recruiting patients for trials (potentiated by evolution in
medical practice featuring tertiary center care only for the
very sickest patients) and in obtaining institutional approv-
als for studies and contracts is tending to drive industry to
non–academic center partners for performance of clinical
trials when this strategy is feasible. To the problem of
academic center inefficiency is added the problem of over-
head costs which support the academic machinery, also
tending to make the academic center less attractive than the
growing cadre of alternatives for industrial contracts.
It is clear that important symbiosis and synergy exist
between academic cardiology and industry. However, loss of
the distinction between these entities is inherently danger-
ous. Research entails free inquiry which often fails to
support preconceived ideas. Serendipitous findings, and
resulting development of new lines of inquiry, must allow
the capacity for failure. By its structure and purpose,
industry must minimize failed efforts and must focus its
resource allocations toward prespecified applications of new
knowledge. Thus, industry is most efficient if its work is
based on fundamental knowledge which already has been
developed and tested. Redevelopment of the academic
environment within the industrial sector inherently is un-
economical and is unlikely to occur in the foreseeable future.
Conversely, in the absence of an environment which fosters
unfettered inquiry, new knowledge is unlikely to develop at
the rate our society implicitly has come to expect. Without
the creation of new knowledge, neither industry nor cardio-
vascular health will be served.
Current research funding for academic cardiology and its
limitations. The future of cardiovascular medicine depends
on the creation of new knowledge resulting from high
quality clinical research and clinically relevant basic research.
These efforts require well trained and experienced investi-
gators, a collegial atmosphere, protected time, highest
quality facilities and financial support. By their organization
and tradition, academic cardiovascular centers are best
positioned to produce new knowledge from cardiovascular
research. Unfortunately, the productivity of clinically
trained cardiovascular researchers is being eroded by in-
creasing pressure to enhance diminishing clinical revenues,
loss of time due to increasing requirement for redundant
documentation and other administrative burdens and the
performance of nonreimbursed activities, including teach-
ing. Today, clinical reimbursements no longer are sufficient
to subsidize otherwise unfunded research efforts; sources of
funding specifically earmarked for research also are in
jeopardy. Although research funding has increased during
the past decade, research costs have increased even more
rapidly, in part due to the complexity of modern research
and its associated facility and specialized labor requirements.
The public demand for research products also appears to
have increased, fueled by the successes of the recent past.
This factor, as well as the increased emphasis on research as
a measure of excellence of academic centers, has led to a
marked increase in the number of investigators, especially in
basic science disciplines, resulting in heightened competi-
tion for research support. Consequently, a progressively
increasing proportion of investigator time must be devoted
to obtaining research support (5).
As this overview suggests, during the past three decades,
financial support of U.S. medical schools has changed
dramatically (Table 1) (5). Total support from all sources
has increased. However, as a proportion of total funding,
support from the federal government has decreased and has
been replaced by reliance on revenues generated within
academic institutions. Such self-support, which includes
revenues from practice plans, hospitals and clinics, as well as
from tuition, fees and allocations from the parent university,
increased from 17% to 57%, whereas support from the
federal government decreased from 54% to 21%. However,
self-support is precisely the component most adversely
affected by recent health care reforms.
Though total funding for medical schools has increased
since 1965, the proportion allocated to research has de-
creased. Overall research expenditures have decreased more
than 25% as a proportion of total health care expenditures.
Thus, from 1970 to 1994, the gross domestic product
increased from $1,036 billion to $6,931 billion, a near
sevenfold increase; during this same period, national health
care expenditures increased from 3.8% to 14.7% of the gross
domestic product (more than a 25-fold increase in total
expenditures) and reached $1,021 billion in 1995. However,
since 1965, the proportion of health care expenditure
allocated to research has fallen from 4.8% to the current
Table 1. Financial Support of U.S. Medical Schools (% of Total)
Source of Funding
Years
1965–1966 1975–1976 1985–1986 1995–1996
Federal government 54 37 25 21
State/local government 16 28 22 12
Self-support* 17 23 43 57
Other† 12 12 10 11
*Self-support includes revenues from practice plans, hospitals and clinics, as well as from tuition, fees and parent university
support. †Other includes endowment and developmental funds, foundation grants and private philanthropy. Modified from:
AAMC Data Book: Statistical Information Related to Medical Education. Washington (DC): Association of American Medical
Colleges, 1998, Table D1.
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level of approximately 3.5%, where it has remained since
1989 (5).
As allocation of health care funds has changed, so too
have the sources of research financing (5). The dramatic rise
in total health care expenditures since 1970 has been
accompanied by a slower growth in National Institutes of
Health funding, which has risen 15-fold during this period
(actual dollars). Moreover, though apparently substantial in
absolute dollars, this increase in National Institutes of
Health funding must be viewed in the context of the
explosion of complex technology and associated costs that
has occurred during this period. Research funding require-
ments have been made up in part by industry; industrial
contributions to academic research have jumped 41-fold
during the same period. However, industrial research gen-
erally is directly tied to product development and is less
likely to be investigator-originated than National Institutes
of Health funding.
Though research funding has lagged, public expectations
for medical progress have increased, fueled by the successes
of the 1970s and 1980s. Simultaneously, in response to a
“doctor shortage” predicted in the 1950s and 1960s, the
number of medical school graduates and PhD scientists has
grown markedly. Cardiovascular specialists also have in-
creased, though it may be argued that their number has not
increased in proportion to the growth of new knowledge
which they are specifically trained to apply. In recent years,
the increase in researchers has exceeded the increase in
research funds, leading to heightened competition for re-
search support and a growing disenchantment with research
as a realistic career option. The recent dramatic reductions
in clinical fee structures have compounded the problem.
Thus, with diminishing federal support, academic medical
institutions have depended increasingly on clinical remuner-
ation for survival, and reductions in fees have led to
extraordinary pressure on clinically trained academic faculty
to devote increasing time to clinical activities to maintain
total remuneration. In earlier times, clinical income, as well
as more readily available training grants, commonly were
employed to support the initial research efforts of trainees
and junior faculty, as well as new lines of investigation by
established researchers. This “seed funding” enabled the
generation of data to support subsequent applications for
peer-reviewed extramural funding. These opportunities are
progressively diminishing, with a concomitant fall in the
proportion of junior faculty members who are successful in
establishing a career of clinical research or clinically relevant
basic science research.
Increasing research costs and increasing competition for
available research dollars (as evidenced by the current,
historically low 16% rate of funding National Institutes of
Health RO1 grant applications) both have contributed to a
reduction in the frequency with which MDs now enter
cardiovascular research. These issues are compounded by
dramatic alterations in the requirements of modern clinical
practice of cardiovascular medicine which have led to
increased clinical subspecialization in both invasive (e.g.,
interventional cardiology, electrophysiology) and noninva-
sive (e.g., echocardiography, transplantation medicine) ar-
eas. Such subspecialization now requires intensive and
lengthy training and prolonged experience for acceptable
competence, minimizing time available for research by
many cardiovascular physicians, except as the research may
relate to evaluating new equipment, drugs and techniques.
In 1995, 19,152 physicians in the U.S. were classified as
cardiovascular physicians (6). Of these, only 775, or 4%,
identified themselves as devoted primarily to research.
Because of the increased competition for research funds,
successful research proposals must be of higher quality and
supported by greater quantities of “preliminary” data than in
earlier decades. Three products of this apparently salutary
trend require comment. First, the need to justify the goals of
new proposals with preliminary data, in the context of
increasingly limited funding to support acquisition of these
data, minimizes the opportunity for new researchers to
obtain peer-reviewed funds. Second, the requirement for
preliminary data, most readily available from previously
funded investigators, tends to diminish funding for explo-
ration of new ideas not generally accepted by the research
establishment. Third, with limited “seed” funds for research
by clinical trainees, the growing requirement for “prelimi-
nary” data minimizes the opportunity for clinicians to
compete effectively for peer-reviewed research dollars, fore-
closing future research options (7). The net effect of these
trends is diminution of clinician involvement in research.
Attempts by academic centers to minimize negative
financial trends by capturing more clinical health care
dollars have been thwarted, in part, by the inherent disad-
vantages of academic centers in competing for clinical
market shares against nonacademic providers. As noted
above, funding for medical research and education are
becoming increasingly limited. However, it remains an
inalienable responsibility of academic centers to teach new
physicians and to create new knowledge through research.
Therefore, available resources must be deployed to effect
these responsibilities as well as to support clinical service.
Traditionally, departments of medicine have subsidized
relatively less profitable divisions from clinical cardiology
revenues. Though reimbursements have diminished, the
tradition of taxation has not, further handicapping academic
divisions of cardiology in their capacity to undertake re-
search.
As noted previously, the loss of sources of research
support has resulted in ever greater dependence on industry.
Even in this area, in which academic medical centers have
exercised a virtual monopoly, new competition has devel-
oped (8). Clinical research organizations now frequently
employ nonacademic physicians to perform clinical research
and centralized industrial data managers to document and
analyze data. The outsourcing of pharmaceutical research is
due to both nonfinancial and financial factors. The primary
problem for the academic center is its inefficiency in
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recruiting patients and delivering the research product
required by industry. This problem is attributable, in part, to
the increasing capacity for outpatient management of pa-
tients even with relatively severe disease. The result is that
the academic center tends to attract the sickest and most
complex patients, who may not meet the rigorous inclusion
and exclusion criteria for modern drug trials. This factor is
compounded by the relatively high indirect costs in aca-
demic medical centers, needed to support other institutional
priorities, and by the administrative complexities and delays
involved in developing contractual relations between indus-
try and academic centers. The result is that clinical research
organizations and pharmaceutical manufacturers seek alter-
native sites for applied clinical research.
The Current Status of Research in Academic Cardiology
The researchers. Researchers in academic cardiology are
drawn from the faculties of medical schools. Precise infor-
mation about research activities of specific faculty subgroups
is not available. However, some inferences can be drawn
from data gathered for the 1994–1995 report of the Asso-
ciation of Professors of Cardiology from 109 of the 116
member academic medical centers in the United States.
Response rates by geographic region are listed in Table 2
and show the size of the full-time academic workforce.
Data from the reporting institutions are tabulated by
faculty rank (Table 3) and by faculty job description (Table
4).
Breakdown of faculty is not available in these surveys by
1) basic research versus clinical activities, 2) type of medical
affiliation, 3) race and ethnicity, or 4) gender. In addition,
this database does not include researchers in government,
industry, private research institutions and nonacademic and
nonphysician researchers performing clinical research.
However, the newly restructured American Heart Associa-
tion National Research Awards provide some, albeit lim-
ited, data regarding proportion of MDs versus PhDs and
distribution of women and members of minority groups in
academic cardiology research that receives peer-reviewed
funding.
In 1996 there were 1,450 applications for the .$52
million research grants (9) (Table 5).
Those with MD degrees fared less well competing for
scientist development grants but had similar success to
PhDs for established investigator grants and grant-in-aid
support (Table 6).
Thus, American Heart Association research funding was
directed at young faculty but also was available to more
established investigators.
Women are applying in greater numbers than in the past
though, for scientist development grants, established inves-
tigator grants and grant-in-aid support combined, female
applicants are outnumbered by male applicants by 3 to 1.
Nonetheless, evidence indicates funding levels are compa-
rable to those of men. American Heart Association funding
of minority group members now comprises 6% of total
research funding.
Similar data can be obtained from the National Heart,
Lung, and Blood Institute. However, these statistics char-
acterize only the principal investigators, do not represent the
total pool of funded investigators and cannot be extrapo-
lated to industry-based funding.
Funding sources and sites of clinical cardiology researchTable 3. Number of Academic Faculty by Academic Rank,
1994–1995
Academic Rank Total in USA
Instructor 95
Assistant Professor 801
Associate Professor 532
Professor 544
Other 41
Total 2,013
Table 4. Number of Academic Faculty by Job Description,
1994–1995
Job Description Total in USA
Chief/Associate Chief 157
Clinician 455
Critical care unit staff 102
Echocardiography staff 326
Catheterization staff 200
Electrophysiology staff 193
Nuclear staff 58
Transplantation 72
Research 137
Non-MD 124
Other 155
Table 5. Percentage Applicants and Percentage Receiving Funds
by Degree
% Applicants % Receiving Funds
MDs 27% 23%
MD/PhDs 12% 15%
PhDs 60% 62%
Table 2. Institution Response Rates
Region
Institutions
Responding
Northeast (CT, DC, MA, MD, NH,
NJ, NY, PA, RI, VT)
39 of 39 (100%)
South (AL, AR, FL, GA, KY, LA, MS,
NC, OK, PR, SC, TN, TX, VA, WV)
32 of 34 (94%)
Midwest (IA, IL, IN, KS, ND, NE,
MI, MN, MO, OH, SD, WI)
24 of 29 (83%)
West (AZ, CA, CO, HI, NM, NV,
OR, UT, WA)
14 of 14 (100%)
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currently are changing, affecting the traditional research
opportunities and activities of the academic cardiology
community. As discussed above, non–academic-affiliated
research institutes are increasing in number and are involv-
ing community physicians in clinical research, enabling
improvement in patient recruitment efficiency, as well as
reduction in research costs by eliminating or minimizing
institutional overhead charges. Consistent with this trend,
large trials conducted under the auspices of industry or of
the National Institutes of Health now commonly involve
research grants paid on a per case basis rather than by
prepaid contract, whether investigators are full-time aca-
demics or private practitioners.
According to the data compiled by the Association of
Professors of Cardiology, inpatient responsibilities alone
(attending assignments and procedures) account for 70% of
available full time equivalents (FTEs) in divisions of cardi-
ology. This distribution of effort leaves only a relatively
small proportion of faculty time and effort for outpatient
clinical responsibilities, teaching and research. The Associ-
ation of Professors of Cardiology concluded that there is a
mismatch between faculty size, workload and funds gener-
ated, leaving faculty with increasing responsibilities and
diminishing time for research. Data to support these con-
clusions are relatively sparse. Therefore, for purposes of this
conference we undertook an informal survey of eight major
academic medical institutions, conducted via specially de-
signed questionnaire (Table 7). This survey indicates a 13%
increase in faculty time assigned to clinical service, with a
concomitant 11% reduction in research time. (The differ-
ence is attributable to variation in teaching responsibilities.)
Data defining retention of cardiology faculty in academic
medical centers also are relatively sparse. The Association of
Professors of Cardiology reports that faculty numbers have
been stable during the past few years, but information
specific to the research segment of the faculty is unavailable.
Nonetheless, for all medical school disciplines, Moy et al.
reported an inverse relation between growth of National
Institutes of Health awards during the past decade and
managed care penetration among U.S. medical schools (10).
Our informal survey (Table 7) supplements and tends to
support the Association of Professors of Cardiology report,
indicating that, during the past two years, faculty reductions
due to lack of research funding occurred in only one of the
eight institutions queried. Other aspects of the survey,
including those related to faculty stability, training and
funding, are reported in Table 7.
Although wide variability is discernible among the re-
spondents to this informal survey, some patterns seem
relatively consistent. The proportion of faculty positions
primarily supported by research funds has decreased during
the past 10 years and, with it, so has faculty time devoted to
research. Faculty size has been relatively stable, but time
devoted to clinical service has increased, whereas time
devoted to teaching has remained constant. There is a
modest trend toward increased hiring of PhDs and a clear
reduction in dependence on National Institutes of Health
funding for research, with a concomitant increase in funding
from industrial sources. The majority of cardiology fellows
devote less than a year to research during their training,
though some institutions now require more than a year of
research for all their fellows. Most research at the fellow
level is clinical, and a small minority of fellows, involving a
small proportion of institutions, receive no research experi-
ence at all. These findings tend to support the concerns
raised in other sections of this report regarding the demise
of the clinician–investigator and the difficulties in maintain-
ing traditional cardiovascular research productivity levels in
the academic medical center.
Factors affecting research performance. Just as clinical
cardiology has required progressively lengthy training periods,
so too there has been an increasing realization that high
quality research requires more than the traditional, relatively
limited, apprenticeship with an established mentor. Increas-
ingly, physician research training involves intensive and
time-consuming commitment to the mastery of research
methodology, including the fundamentals of hypothesis
generation and study design, as well as expertise with
complex technology. In the past, these standards were
applied only to PhD training. Today, it is recognized that
MD researchers must be trained similarly, and that clinical
as well as basic research must be held to rigorous standards.
Given the increasing time commitments required for both
clinical cardiology and for cardiovascular research, profi-
ciency by a single physician in both areas will become
Table 6. Percentage Applicants and Percentage Receiving Funds by Grant Type and
Academic Rank
SDG EIG GIA
%
Apply
%
Funded
%
Apply
%
Funded
%
Apply
%
Funded
Professor 21% 17%
Associate Professor 27% 26% 31% 35%
Assistant Professor 53% 51% 68% 68% 34% 32%
Instructor, postdoctoral 16% 49%
SDG 5 scientist development grants; EIG 5 established investigator grants; GIA 5 grant-in-aid support.
1114 Borer and Vogel JACC Vol. 33, No. 5, 1999
Task Force 2: Research April 1999:1091–135
Table 7. Survey of Research in Divisions of Cardiology: Responses
1. What % of faculty positions are primarily research funded (.50% salary from research)
10 years ago: 35% (range 5 0 to 65%)
Now: 21% (range 5 0 to 60%)
2A. What is the time distribution of the entire cardiology faculty?
Clinical
10 years ago: 52% (range 5 25% to 75%)
Now: 65% (range 5 40% to 75%)
Research
10 years ago: 35% (range 5 15% to 65%)
Now: 24% (range 5 10% to 50%)
Teaching
10 years ago: 13% (range 5 10% to 20%)
Now: 11% (range 5 5% to 17%)
2B. What is the average clinical time (%) for an average tenure track assistant professor?
10 years ago: 39% (range 5 10% to 60%)
Now: 57% (range 5 20% to 80%)
3. Number of faculty let go due to decrease in research funding support in the past 5 years.
Average 5 2 positions (range 0 to 5)
4. How many PhDs are in your division of cardiology?
10 years ago: 3 (range 5 0 to 14)
Now: 5 (range 5 0 to 20)
5. What is the training experience for new faculty hired at Assistant Professor level in the past 5 years?
Approximately half the newly hired assistant professors have had standard 3- or 4-year cardiology fellowships without special
research experience, and approximately half have had a 3- or 4-year fellowship plus PhD training or at least 1 full year devoted
to research.
6. What % of assistant professors remain in your academic cardiology division/department for .5 years?
Tenured: 51% (range 5 ,10% to 95%)
Nontenured: 47% (range 5 20% to 70%)
7A. Change in the # of faculty positions in the division of cardiology over the past 5 years.
Average 5 11 (range 5 23 to 18)
7B. As we continue to train academic cardiologists, what is your prediction of job opportunities in academics for finishing trainees?
Few: 25% of respondents
“Some”: 50% of respondents
Many: 25% of respondents
8. What are the sources of funding for research in your division?
NIH
10 years ago: 51% (range 5 20% to 80%)
Now: 43% (range 5 0 to 70%)
Pharmaceutical industry
10 years ago: 37% (range 5 5% to 80%)
Now: 46% (range 5 5% to 80%)
Biotechnology
10 years ago: 4% (range 5 0 to 25%)
Now: 9% (range 5 0 to 25%)
Other
10 years ago: 8% (range 5 0 to 40%)
Now: 12% (range 5 0 to 75%)
9A. In what type of research projects are cardiology fellows participating?
Clinical: 60% (range 5 5% to 90%)
Basic: 36% (range 5 0 to 95%)
None: 4% (range 5 0 to 15%)
9B. How much time do your fellows devote to research?
0 to 3 mo: 13% of fellows (range 5 0 to 80%)
3 to 6 mo: 24% of fellows (range 5 0 to 75%)
6 mo to ,1 yr: 19% of fellows (range 5 0 to 80%)
1 yr: 10% of fellows (range 5 0 to 40%)
.1 yr: 38% of fellows (range 5 0 to 100%)
The Subcommittee on Research Issues surveyed eight institutions to assess the research environment in academic medical centers. Participating centers include University of
California at Los Angeles, Medical College of Virginia, George Washington University Medical Center, Johns Hopkins, University of Maryland, Cornell, Utah and New Mexico.
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increasingly uncommon. Indeed, survival of the clinician–
investigator will require creative restructuring of training
opportunities and of research funding.
As a result of the increasing dichotomy between clinical
and research activities, compartmentalization of faculty into
research and clinical practice tracks has increased and often
is acknowledged as a separation into tenure and nontenure
tracks. Furthermore, whereas clinical research is understood
to require clinical faculty, basic research does not. In the
past, a compelling reason for performing basic research in
clinical departments has been to gain the perspective af-
forded by the clinician–scientist in disease-related research.
When the role of the clinician–scientist in research is
minimized, this valuable element is lost. The compartmen-
talization of faculty into research and clinical practice
sections affects two important elements of the academic
milieu, compensation and peer attitudes. In her presidential
address to the American Society of Clinical Investigators,
Swain stated that, “Since clinician–scientists perform activ-
ities almost identical to faculty members in basic science
departments, they should also expect that their personal
compensation be similar to faculty members in basic science
departments” (11). The implication of this statement is that
the base salary of the clinician–investigator should take
account of service to the medical center as research. The
statement underscores the fact that clinician–scientists pro-
vide clinical teaching of medical students and house staff
and serve on house staff selection and review committees in
addition to the full range of faculty committees, all generally
without specific remuneration or other recognition and all at
the expense of potential research involvement.
Peer-reviewed funding during the past decade increasingly
has emphasized cellular and molecular genetic techniques and
concepts. The strength of the clinician–investigator is in the
study of patient-related problems and integrative physiology.
However, molecular biological studies most commonly are
undertaken in isolated systems from which the confounding
influences of many physiologic variables have been removed.
As a result of this reductionist emphasis, the role of the
traditional integrative physiologist has been diminished in both
clinical and basic science departments. Moreover, the simpli-
fied models commonly used in reductionist systems tend to
result in data that are difficult to apply to hypotheses at the
organ or organism level, as is required for solution of clinical
problems in cardiovascular diseases. The emphasis on such
simplification may be true even at the level of awards, like
National Institutes of Health Specialized Center of Research
(SCOR) grants, that are meant to emphasize integrative
studies.
Because of these trends, major research efforts in many
clinical departments have shifted from integrated interdis-
ciplinary studies to large scale clinical trials. This has had
some salutary results insofar as such trials can help reorient
clinical practice toward evidence-based, scientific decisions.
Several clinical trials, such as the Cardiac Arrhythmia
Suppression Trial, have shown that logical but unchallenged
clinical practices can lead to unforeseen outcomes and need
to be subjected to scientific scrutiny (12). However, even for
evaluation of common clinical problems, sample size re-
quirements frequently necessitate multicenter national and
international cooperation, with substantial attendant orga-
nizational complexities. These undertakings require enor-
mous resources compared with standard National Institutes
of Health awards. Universities have recognized both the
intrinsic importance of these studies and the large indirect
cost allocations that such programs can generate for medical
schools. As a result, many major centers have established
clinical research units that enjoy substantial autonomy from
the traditional departments of medicine. These units bring
together clinicians, biostatisticians, data managers and
health economists; they can fill a very important role in
educating clinical investigators, potentially providing formal
and/or mentored training in clinical epidemiology, biosta-
tistics and outcome analysis. In some fellowship programs
associated with these units, formal training is combined
with a thesis requirement aimed at qualifying trainees for
masters or doctoral degrees in Health Sciences. Such devel-
opments entail many obvious benefits in terms of research
products and research funding. However, such specialized
training may tend to further insulate the basic researcher
from the clinician–investigator, and both from the clinical
practitioner. The optimal reintegration of these different
facets of the academic spectrum has yet to be achieved.
In sum, several factors appear to threaten the survival of
the academic clinician–investigator, including: 1) the
changing health care financial environment, 2) rapid
changes in biomedical science and technology, 3) the
lengthy period of requisite research training, 4) emphasis on
basic rather than clinical research in peer-reviewed funding,
5) outsourcing of clinical trials to community facilities, 6)
competition for research funds, and 7) limitations on
protected time (13).
Limitations of current research training. Ideally, research
training in academic cardiology should provide a wide
spectrum of instruction involving didactic and experiential
components; these should include elements of scientific
theory, basic and clinical research techniques, integrative
and health outcomes research concepts and techniques,
epidemiology and biostatistics. Many successful investiga-
tors currently in academic cardiology did not receive this
breadth of formal research training but often experienced 1
or more years of total immersion in research through service
at the National Institutes of Health or through postdoctoral
fellowships. This informal track has almost disappeared
during the past two decades. Training now generally is
provided in the context of combined MD/PhD programs
for physicians who seek a career primarily in research.
Furthermore, PhD programs increasingly provide nonphy-
sician researchers for academic medicine. Some informal
research experience also is provided in MD training pro-
grams without PhD requirements, but such experience
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generally is devoid of any focus specifically on research
methodology.
PHD PROGRAMS. The current trend of isolated PhD train-
ing is toward a narrow focus. The trainees spend most of
their time in one laboratory addressing one issue in great
depth. Indeed, depth is a key goal of most PhD programs.
Therefore, today’s PhD candidates may be gathering a
smaller portion of the broad base than in previous years. In
parallel with the disappearance of the traditional integrative
physiologist, the greatest limitation on current biomedical
PhD training is the limited exposure to the pathophysiology
of disease and integrative systems. This minimizes ability to
recognize findings with clinical relevance.
To be more suitable for training in clinical or clinically
oriented research, PhD programs will need to incorporate
rigorous training in integrative physiology and clinical
pathophysiology. This has been achieved in some institu-
tions by incorporating medical school classes on integrative
physiology, anatomy and clinical pathophysiology into the
graduate school curriculum. For this trend to be supported
meaningfully, a reorientation will be needed in the
philosophy underlying criteria for acceptable peer-
reviewed funding.
MD AND MD/PHD PROGRAMS. The degrees of exposure to
research concepts varies dramatically among medical
schools. Most provide an opportunity to acquire both
degrees simultaneously, and a few integrate PhD training
with post-MD medical training. In the absence of PhD
training, the emphasis on teaching formal scientific
thought and techniques in MD programs varies from
minimal to extensive. Currently, the predominant focus
of medical education is on the production of primary care
practitioners rather than subspecialists. Consequently,
most medical students are exposed to a less research-
oriented curriculum than in earlier eras. At the level of
residency and fellowship, the Accreditation Council for
Graduate Medical Education currently requires meaning-
ful supervised research exposure with protected time. In
addition, the American Board of Internal Medicine offers
a special research pathway emphasizing investigation. For
residents and fellows interested in careers in private
practice, the “protected research time” often is used to
learn techniques which can be applied in clinical service,
further reducing true research exposure. For residents and
fellows interested in academics, the quality of the re-
search experience varies widely. It can be as limited as a
chart review project. Alternatively, it can be valuable
experience in rigorous, hypothesis-oriented investigation
leading to publications and eventual research indepen-
dence.
Ideally, training for clinician–investigators should com-
bine the instruction in scientific concepts and methodology
provided in PhD programs with the awareness of clinical
relevance provided in MD training. This approach would
prepare the clinician investigator for high quality research
efforts, for a useful role in the integration of research results
into clinical medicine and for competitiveness in seeking
funding for clinical, basic, integrative or outcomes research.
RESEARCH TRAINING FOR NONACADEMIC CLINICIANS. At
present, most nonacademic clinicians involved in clinical
research have obtained their training “on-the-job.” Formal
training in research methodology, and even meaningful
mentoring in the conceptual bases of clinical investigation,
usually are lacking. Despite these limitations, clinical trials
performed by nonacademicians often are of high quality
when the sponsoring organization or industry provides a
suitable research protocol.
Recommendations and Conclusions
From the foregoing review of the current status of
cardiovascular research at the academic medical center, it
is clear that a crossroads has been reached. The explosion
of scientific knowledge and technological capacity during
the last quarter century alone has led to increasing
divergence in requirements for training and technical
expertise for those who practice clinical medicine and
those who create new knowledge through biomedical
research. This factor promotes separation between clini-
cians and researchers. The situation has been com-
pounded by economic forces which tend to demand that
those physicians who provide clinical services must pro-
vide them more efficiently, that is, in greater quantity per
unit of time, and for lesser remuneration, than in the
past. Simultaneously, funding for independent research
has not kept pace with total medical expenditures, with
our gross national product or most importantly, with the
costs of modern research and the demand for high quality
research products. Simultaneously, the source of research
support has shifted increasingly from the peer-reviewed
public or quasi-public nonprofit sector to the applied,
profit-driven industrial sector. The result has been to
minimize resources of time and money available to
support independent research activities by clinically
trained and clinically active cardiologists. Together, these
trends have jeopardized the existence of the traditional
clinician–investigator and, consequently, threaten the
rate of development of clinical advances in cardiovascular
diseases.
To be sure, this situation may be altered beneficially as
evaluation and treatment modalities are introduced that
depend on knowledge of cellular and molecular biology.
When such developments occur, medical education and
training necessarily will more fully incorporate the knowl-
edge base necessary to assimilate and use these modalities
(perhaps by an economically unpalatable increase in the
duration of medical schooling and training), and a new
cadre of clinician–investigators may emerge. Currently,
however, the development of this new world does not
appear imminent; in the interim, the problem of maximiz-
ing the development of clinically applicable new knowledge
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remains. The greatest concern is that the demise of the
clinician–investigator will mitigate against the optimal
shaping of research priorities for the purpose of translating
fundamental and preclinical developments into clinically useful
new knowledge. As a corollary, of course, emergence of a new
clinician–investigator model would not necessarily remediate
the associated difficulties in research funding. To overcome this
problem, we must resolve the intertwined impediments of the
relative paucity of new clinician investigators and the relative
lack of resources to support independent clinically applicable
research. Several potential solutions are apparent from our
review. These strategies are not mutually exclusive and, in fact,
should be pursued simultaneously to expand the range of
options for furthering cardiovascular research.
Recommendation #1: development and support of the
clinician–investigator. Support for the training and devel-
opment of new clinician–investigators is central to our
proposed strategy to revitalize the academic medical center
in the production of cardiovascular research. This strategy
requires funding for rigorous, formal training in research
methodology for clinicians committed to an important role
in research. Training for these investigators must include
specific programs in hypothesis generation, study design and
other fundamental elements and principles of research and
of the scientific method, all relatively underemphasized in
medical schools today and almost totally lacking in many
postgraduate programs. Incorporation of the study of re-
search methodology would be appropriate in the medical
school curriculum, but may not be realistic within the
current time constraints and the contemporary national
priority for education of primary practitioners. MD–PhD
programs offer one route around this dilemma, but may not
involve those who, ultimately, will have greatest clinical
expertise. Therefore, the academic medical center will need
to design and offer rigorous training in research methodol-
ogy for clinicians. It is understood that, in the current era,
optimal research strategy often may require interdisciplinary
teams, of which clinician–investigators should be integral
members. However, there remain many instances in which
high quality and productive individual research efforts are
feasible; in many instances these, too, can be undertaken by
clinician–investigators.
Recommendation #2: the clinician–investigator “surro-
gate”: interdisciplinary clinician–investigator groups.
When, by virtue of the complexity of the research problem,
it is not feasible for a single individual to fill the role of
clinician–investigator, the function must be subserved by
some other organization of effort. The most obvious candi-
date would be interdisciplinary groups focused on aspects of
specific clinical problems. Interdisciplinary groups could be
structured on an ad hoc basis, with size and composition
appropriate for the proposed project. However, generally,
they should include at least one member with expertise in
study design, at least one member with relevant basic
science expertise when clinical projects are being considered
and at least one member with relevant clinical expertise when
basic science projects are being considered. The potential for
useful employment of nurse PhDs in such interdisciplinary
groups deserves special mention; these scientists bring unique
clinical insights as well as expertise in their areas of doctoral
study. In certain settings, interdisciplinary groups may be
organized most effectively by empaneling representatives from
more than one institution. Though the possible loss of frequent
direct contact is a potential problem, a well organized inter-
institutional approach may become increasingly feasible as
communications technology progresses.
Recommendation #3: education, training and interaction
of interdisciplinary groups. To enable implementation of
recommendation #2, the following actions will be useful.
CLINICAL EDUCATION FOR NONCLINICIANS. Training of
nonphysician biomedical researchers, and nonclinically
focused physicians, will need to incorporate specific
elements to assure knowledge of the characteristics of
cardiovascular diseases. Because PhDs are not necessarily
interested in clinical problems, this solution may require
some reacculturation. In addition, PhDs focused at the
most fundamental levels of research also may need
additional grounding in the principles of study design, as
opposed to experimental design. The level at which the
new training must occur is not immediately obvious, but
probably will need to be offered within academic medical
centers both to postdoctoral fellows and to established
faculty through rigorously designed programs. Past ef-
forts at such training have been limited, and results have
not been encouraging. Therefore, metrics will need to be
established to evaluate the efficacy of training programs
and to enable modification as needed.
TRAINING IN RESEARCH METHODOLOGY FOR THE CLINI-
CIANS. As a corollary (see recommendation #1), clinician–
investigators must be created for involvement in interdisci-
plinary groups. This process must include rigorous,
structured training in research methodology, as previously
noted.
REGULAR, PLANNED AND MUTUALLY EDUCATIONAL INTER-
ACTIONS OF THE GROUP. The appropriately trained inves-
tigators must interact regularly to create a community of
interest which will allow them to understand each other’s
cultures and to develop mutually accepted project goals.
Such interaction implies a commitment of time and effort to
understand conceptually the specific methods and contribu-
tions of different group members. This commitment may
require exploration of literature outside the immediate areas
of expertise of individual group members.
Recommendation #4: public and quasi-public funding
to enable formation (including requisite training) of
the new group entities. Funding mechanisms must be
devised to support development of the new clinician–
investigators and interdisciplinary groups, including the
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training programs envisioned in recommendations 1 to 3.
Because of increasing constraints on unrestricted funds
for academic centers, research training for clinicians will
require commitment of public funds, most appropriately
through the National Institutes of Health. Novel means
of creating public funds (e.g., an all payers tax) may be
justified by consideration of the resulting public good.
Publicly funded efforts can build on the K30 program
recently announced by the National Institutes of Health,
which provides limited funding for academic centers to
develop curricula to train clinicians in research methods.
Federally sponsored enabling grants should be supported
by similar enabling instruments from other quasi-public
nonprofit sources (American Heart Association, Ameri-
can College of Cardiology and others). In the short term,
development of such funding instruments may reduce
funds available for independent research. This may be a
burden we must bear. However, when public funds are
used, ultimately they must be justified via a political
process. It follows, then, that the academic cardiology
community must develop a cogent and understandable
case supporting its views and must bring this case to the
public and to the public’s elected representatives. This
responsibility devolves on us individually, but also should
be an important focus of our professional organizations
and, specifically, of the American College of Cardiology.
Recommendation #5: mechanisms enabling industrial
funding, and enhanced public funding, of investigator-
initiated research. Additional funding may be available
from industry. To define appropriate areas for industrial
funding, a continuing dialogue for this purpose must be
maintained between industry and academic cardiology, in-
volving a forum for identifying areas of mutual interest and
concern. The American College of Cardiology has initiated
such dialogues, and should accept major responsibility for
their enhancement and maintenance. Industrial grants re-
sulting from such mutually determined needs should be
awarded by external peer review, with results available to
industry for profit-making activities according to some
formula based on the magnitude of the initial investment.
Alternatively, the funding goal may be achievable by devel-
opment of agreements between individual academic centers
and individual industrial concerns which allow shared profit
from the application of independent research. In addition,
concomitant with federal commitment for funding research
training for clinicians, a federal commitment is needed for
increased funding of research efforts led by clinician–
investigators. This requires an attitude shift by the National
Institutes of Health to recognize the value of traditional
clinical research; recent National Institutes of Health initi-
atives indicate that this shift is under way.
Recommendation #6: reasonable cost-accounting of cur-
rently unremunerated academic activities by clinical fac-
ulty, with development of appropriate rewards. Aca-
demic medical centers must analyze their operating budget
formulae, must provide reasonable cost-accounting of here-
tofore unremunerated academic activities by clinicians and
must provide rewards of some form for this activity, creating
an opportunity for “protected time” for research. Among the
financial arrangements which require review is the widely
applied policy of taxing cardiology activities, and particularly
procedural activities, more heavily than clinical activities in
other areas of internal medicine to support work in noncar-
diology disciplines. In the context of diminishing revenues
for clinical services, and particularly for cardiac services,
such policies must be reconsidered in favor of similar
financial treatment of all clinical divisions in academic
medical centers.
Recommendation #7: organized interactions with the
nonmedical public. Public and private funding for aca-
demic efforts in cardiology depend upon shared belief in the
value of research by medical researchers and by the general
public. Cardiology, through its professional organizations,
must develop programs to heighten knowledge and aware-
ness of the public regarding cardiology research, including
its methods, its successes and the relation between resource
availability and the potential for meeting public expecta-
tions. The planned activities during the 50th Anniversary
celebration of the American College of Cardiology can be
expected to begin this process, and will serve as a test bed for
methodology for future efforts.
The creation of new knowledge and its clinical applica-
tion is a very real requirement of academic cardiology, as of
all academic medicine. If this need is not met, the expecta-
tions of our society will not be fulfilled. However, to resolve
this problem, we will need to expand beyond traditional
patterns of research organization and research financing.
Most importantly, we will need to make a convincing case to
the other sectors of our society to justify the redistribution of
societal resources which will be needed if the medical
progress of the last quarter century is to be maintained.
SUMMARY RECOMMENDATIONS
Academic medical centers must
1. Develop and support clinician–investigators, that is, well
trained researchers who also provide patient care.
2. Expand the focus and contribution of clinician–
investigators by initiating formation of interdisciplinary
clinician–investigator groups comprising basic scientists,
epidemiologists/statisticians, clinician–investigators and
others, focused on complex, multidisciplinary patient-
related research.
3. Provide clinical education for nonclinician researchers
involved in the interdisciplinary groups, and rigorous
training in research methodology for clinician–
investigators.
4. Develop a cost accounting structure for currently unre-
munerated academic activity.
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The American College of Cardiology must
1. Encourage expansion of the National Institutes of
Health extramural clinical research budget, and expan-
sion of parallel public funding sources for cardiovascular
clinical research.
2. Encourage and participate in provision of parallel
patient-oriented research support from quasi-public and
nonprofit sources.
3. Develop mechanisms and supporting dialogue to enable
and enhance industrial funding for investigator-initiated
research, as well as enhanced industry-initiated research.
4. Organize interactions with the nonmedical public to
heighten public awareness of the value of cardiovascular
research.
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Task Force 3: Teaching
Gabriel Gregoratos, MD, FACC, Co-Chair, Alan B. Miller, MD, FACC, Co-Chair
CARDIOLOGY TEACHING AND
THE CHANGING HEALTH CARE SCENE
Teaching is the process whereby knowledge is transmitted
from teacher to student. In the medical arena it takes place
at multiple development levels (medical student, resident,
cardiology fellow, practicing physician and nonmedical
health care personnel) and at multiple sites and venues
(medical school, hospital, clinic, office, invasive and
noninvasive laboratories, professional conferences, bed-
side rounds and small group discussions). Scholarly
teaching is a fundamental objective of the academic
cardiology unit (1).
The teaching of cardiology is critically important in an era
of rapidly developing new technologies for the diagnosis and
treatment of cardiovascular diseases. The clear communica-
tion of information to all levels of trainees has major
implications in patient care. Scholarly teaching can best be
coordinated by clinician–educator faculty in the academic
cardiology unit, who have the knowledge base and under-
standing of the ties between basic and clinical investigation
to balance bias and anecdotal experience with science and
evidence- and outcome-based research.
In the academic cardiology program of the future, teach-
ing will be increasingly evidence-based rather than experi-
ential. Teaching evidence-based cardiology within an inte-
grated health care delivery system adds value to the system
from the standpoint of payers, community providers and
other internal customers. Because cardiovascular disease repre-
sents a ubiquitous and costly component of population-based
health care, the value of the academic cardiologist as an
educator and organizer of evidence-based guidelines and qual-
ity management systems should be obvious to health systems
and other medical care enterprises. The development of value/
outcome standards for the teaching contributions of cardiolo-
gists to these systems will be a major objective of the academic
cardiology units of the 21st century.
The substrate for clinical teaching of both internal med-
icine and cardiology has undergone major changes in the
past three decades as a result of the Medicare Act of 1965
and the emergence of managed care in the 1980s (2).
Although major regional differences exist, these changes
1120 Gregoratos and Miller JACC Vol. 33, No. 5, 1999
Task Force 3: Teaching April 1999:1091–135
have had considerable impact on the clinical teaching of
both internal medicine and cardiology (3,4).
There has been a major shift of clinical care to the
ambulatory setting, and fewer admissions to hospitals solely
for diagnostic workups. Hospitalized patients tend to be
sicker, and the ratio of intensive and “intermediate” care
level patients to stable, less complicated patients is high. As
a result, the total care of these patients has become more and
more fragmented; in the inpatient setting, residents and
cardiology trainees have much less opportunity to exercise
clinical judgment, consider differential diagnoses and de-
velop long-term management plans. For example, patients
with post–myocardial infarction cardiogenic shock are usu-
ally taken to the catheterization laboratory early in their
course and revascularized either percutaneously or in the
operating room rather than remaining in the critical care
unit for hemodynamic monitoring and circulatory support.
There is an increasing number of inpatients with end-stage
congestive heart failure being evaluated for cardiac trans-
plantation—a highly specialized process in which trainees
may not actively participate. Disease states have also
changed dramatically. Patients with rheumatic valvular dis-
ease are rare, whereas patients with coronary artery disease
and heart failure predominate in both hospitals and clinics.
The demands of managed health care systems mandate
that patients admitted to hospitals stay for shorter periods of
time. This rapid turnover results in a disproportionately
higher number of admissions compared with several decades
ago. The combination of a larger number of admissions,
sicker patients and rapid patient turnover increases the
workload of academic cardiology faculty and has an adverse
impact on the training experience of medical students,
internal medicine residents and cardiology fellows.
Faculty time available for teaching has declined in the
past 20 years. There are several reasons for this, as indicated
above, but increasing clinical effort is the major one.
Additionally, the requirements imposed by various health
care systems for precise documentation of faculty involve-
ment with patient care has progressively increased (5). Thus,
time previously spent by faculty in teaching is increasingly
taken up by documentation requirements for reimburse-
ment, and by frequent visits to patients. Furthermore,
clinician–educators are frequently required to perform ad-
ditional activities such as teaching of generalist physicians
and nurses, participating in marketing processes and out-
reach and performing administrative tasks relating to prac-
tice issues.
The changes in the clinical spectrum of patients and
acuity of illness coupled with reduced faculty time for
teaching form the basis for the current concerns regarding
the teaching of cardiology (6).
COMPARING TEACHING IN 1998 AND 1978
The leadership view. To obtain information regarding
teaching in academic cardiology, a questionnaire was devel-
oped and distributed to the cardiology division chiefs at the
Association of Professors of Cardiology annual meeting in
March 1998. A similar questionnaire was distributed to the
cardiology program directors at their annual meeting. Re-
spondents were asked to rate these answers from 1 (strongly
disagree) to 5 (strongly agree). The questions were:
1. Teaching is strongly emphasized at my institution.
2. Teaching is rewarded at my institution.
3. The time I have allocated to teaching is unchanged from
5 years ago.
4. Teaching is more important than the clinical responsi-
bilities for my faculty.
5. Medical students, residents and cardiology fellows com-
pleting training in June 1998 are better trained than their
counterparts 5 years ago.
6. I would be interested in having my faculty participate in
a course in faculty development to improve teaching
skills.
Program directors were asked essentially identical questions
(see Tables 1 and 2 for results).
There were some interesting differences between the two
groups. The division chiefs believed that time available for
teaching had changed over the last five years and that clinical
responsibilities outweighed teaching responsibilities, whereas
the program directors were split on these two answers. The
program directors felt that the recent graduates were better
trained than their counterparts five years ago, but the division
chiefs were split. Both groups believed teaching was empha-
sized at their institution but was unrewarded, and both groups
were interested in faculty development.
Table 1. Division Chiefs Survey Results
Question*
Rating
1 2 3 4 5
1 (n 5 33) 1 2 8 11 11
2 (n 5 32) 4 12 13 3 0
3 (n 5 32) 5 14 3 5 5
4 (n 5 31) 11 15 4 1 0
5 (n 5 31) 4 7 9 5 6
6 (n 5 31) 2 3 6 10 10
*See text for questions.
Table 2. Program Directors Survey Results
Question*
Rating
1 2 3 4 5
1 (n 5 47) 3 1 9 16 18
2 (n 5 48) 8 11 17 12 0
3 (n 5 45) 8 11 4 12 10
4 (n 5 46) 3 10 17 12 4
5 (n 5 49) 4 6 13 12 12
6 (n 5 46) 2 11 11 11 11
*See text for questions.
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A similar questionnaire was mailed to the deans of 143
medical schools in the U.S. and Canada. There were 30
responses. The questions and responses are tabulated in
Table 3. The following main points by the responders are
particularly relevant:
1. Cardiology teaching today is more technical and less
clinical/bedside.
2. Cardiology teaching has been de-emphasized as primary
care training has been emphasized.
3. There was a wide variance of opinion as to whether these
changes were for the better or worse.
4. Almost as many responders indicated that cardiology
teaching today is deficient as indicated it had improved
compared with 1978. An equal number of responses
were noncommittal.
5. Again there was a large variance among responders with
regard to whether teaching was appropriately rewarded.
Almost an equal number indicated that teaching was/was
not emphasized in their institution. The consensus was
that teachers were rewarded in a manner that was
difficult to identify and quantify.
6. Some responders admitted to having no hard data to
support their answers.
7. The majority indicated that faculty development pro-
grams were in force in their institutions.
Similar responses were obtained from a survey of those
attending this Bethesda Conference (Table 4).
The view of the teachers. The learning process has
changed in the past decade as less time is spent at the
bedside and on core knowledge base acquisition. Although
there are wide institutional differences, as a result of expan-
sion of the core curriculum, cardiology material has been
de-emphasized in some medical schools, and involvement of
cardiology educators in the core teaching setting may not be
as prominent. At the postgraduate level the case manage-
ment approach de-emphasizes the physical examination and
history taking at its worst, and at its best, assumes that
Table 3. Dean’s Questionnaire
Question 1:
Has the teaching of cardiology (at both the graduate and postgraduate level) changed in the past 20 years?
Yes: 22/29
No: 7/29
Comments:
Many respondents emphasized that cardiology teaching today is more technical and less bedside/clinical. Several respondents stated
that because of primary care emphasis, cardiology teaching at their institutions was de-emphasized. There was a wide variance of
opinion as to whether changes were for the better or for the worse.
Question 2:
Is the teaching of cardiology now better, unchanged or deficient compared to 1978?
Better: 9/29
Unchanged: 6/29
Deficient: 6/29
6/29 responses were noncommittal, indicating teaching is now different with no evaluation whether it is better or worse. 2/29
responders did not answer this question.
Question 3:
Is teaching in general emphasized/rewarded in your institution? How?
Yes: 13/29
No: 11/29
Equivocal: 5/29
Comments:
There is wide variance among responders, with some emphasizing a complex process of rewarding teaching excellence (faculty rank,
promotion, stipends, awards), whereas others stated teachers were rewarded in a manner difficult to identify and quantitate, and still
others responded flatly that teaching was not rewarded.
Question 4:
Do you have data to support your answers?
Yes: 13/29
No: 9/29
Subjective/no hard data: 4/29
3/29 did not answer this question.
Question 5:
Has your institution established procedures for faculty development to help faculty improve/adjust teaching to changes in clinical
care?
Yes: 17/29
No: 7/29
Equivocal or just beginning: 5/29
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knowledge of history taking and bedside examination skills
are present (7,8). Wide-ranging discussions generated by a
mixture of medical students and interns and residents are
often lost because the groups are divided, medical students
in one group and house staff in another. In some institu-
tions, the small group (two to four students) physical
diagnosis sections have disappeared.
There have been lengthy discussions about the low scores
achieved on questions testing knowledge about physical
findings on the Cardiovascular Board examinations. The
candidates themselves often argue that it is more cost-
efficient (and accurate) to order a cardiac echo than to spend
time with bedside maneuvers to discriminate a murmur.
The American Board of Internal Medicine emphasizes
physical findings by requiring the trainee to be observed
taking a history and performing a physical examination, as
well as by providing a number of questions about physical
examination findings on the Cardiovascular Boards. Despite
this emphasis by the American Board of Internal Medicine,
it appears that some training directors do not emphasize
clinical skills sufficiently. Naturally, clinical skills include
more than a physical examination, and extend to accurate
and thorough history taking as well. There are other
important clinical skills in areas emphasized by the Amer-
ican Board of Internal Medicine (9) that are frequently
neglected because of the emphasis on technological teach-
ing.
The creation of post–training period examinations, often
called certifying or proficiency examinations, by groups that
are not part of the “official” educational process or certifi-
cation mechanism is a new development. For example, the
North American Society of Pacing and Electrophysiology
offers a proficiency examination in pacing called the
NASPEXAM. The American Society of Echocardiography
provides an examination in echocardiography. The Ameri-
can Society of Nuclear Cardiology offers an examination in
their specialty. Most of these societies are careful not to call
this examination a “certification” examination, to avoid the
legal ramifications. In addition, although not the thrust of
this report, several of these groups offer examinations for
technicians as well.
Recognizing the desire of clinicians to have such certifi-
cation, the American Board of Internal Medicine has
created the Institute of Clinical Evaluation (10). This is a
body now separate from the American Board of Internal
Medicine (and therefore separate from the American Board
of Medical Specialties and its rules and restrictions) that will
offer certification in a variety of “niches.” The Institute of
Clinical Evaluation has purchased the American College of
Cardiology electrocardiography examination and will ad-
minister it in 1999. In addition, the Institute of Clinical
Evaluation is working with multiple organizations and is
considering certificates in several other areas.
Teaching ability is perceived by many faculty to be
variable. Inadequate teaching does occur and is difficult to
document in the absence of standard evaluation techniques.
Moreover, objective teaching evaluations are difficult to
obtain. Student and house staff evaluations may not be true
indicators of a teacher’s effectiveness; and faculty are rarely
called upon to evaluate their colleagues’ teaching effective-
ness. Educational research for the development of standard-
ized evaluation techniques is necessary.
Objective data to support the views noted above by
teaching faculty are not available. To the contrary,
available data from the American Board of Internal
Medicine cardiovascular subspecialty examination (Table
5) indicate that the mean scores achieved by candidates
have improved modestly between 1989 and 1997. It is not
clear, however, whether this improvement in scores is
related to changes in content and changes in the level of
difficulty of the certifying examination and may have been
influenced by the increase in training program require-
ments from two to three years.
FACTORS AFFECTING TEACHING
Because of the previously mentioned time constraints, the
attending physician who is focused upon specific aspects of
patient care must assume knowledge on the part of the
house staff/trainee to expedite rounding on patients and not
have to provide “remedial cardiology.” On the other hand,
there is no question that one can teach at the same time as
one does clinical care, provided that the house staff/trainee
is following along; the pace is necessarily rapid and the
experience therefore may be suboptimal. However, it should
Table 4. Bethesda Conference Attendee Survey
Question*
Rating (%)
1 2 3 4 5
1 (n 5 42) 2.4 16.7 31.0 33.3 16.7
2 (n 5 42) 19.0 40.5 28.6 9.5 2.4
3 (n 5 41) 36.6 24.4 19.5 12.2 7.3
4 (n 5 44) 56.8 20.5 20.5 0 2.3
5 (n 5 42) 21.4 21.4 21.4 21.4 21.4
6 (n 5 41) 4.9 14.6 7.3 24.4 48.8
*See text for questions. The Bethesda Conference attendees felt that teaching was
emphasized but not rewarded at their institution. Most felt time for teaching had
changed and that clinical responsibilities were more important. There was no
uniformity in the quality of training now and 5 years ago. The majority favored faculty
development.
Table 5. 1989–1997 Cardiovascular Disease Equated Means
and Standard Deviations
Year
Cardiovascular Disease
n Mean SD
1997 1,838 501 104
1995 1,582 500 97
1993 1,012 490 100
1991 1,500 491 102
1989 1,519 483 108
Reference: American Board of Internal Medicine, unpublished data, 1998.
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not be assumed that seeing patients is somehow a different
activity from teaching about them during the encounter
(rather than later, in a conference room).
Reduction of inpatient base is not necessarily a drawback.
The cardiologist is the only practitioner to whom the
clinic/hospitalist dichotomy does not apply, because the
cardiologist is apt in each area. Indeed the cardiologist must
follow the patient from hospital to clinic and back to follow
the natural history of disease and results of therapy.
Cardiologists have become progressively specialized and
divided into groups such as the electrophysiologist, echo-
cardiographer, interventionalist and so forth. Unless a pa-
tient with a particular problem in the area of expertise of the
subspecialist is presented on rounds, the attending physi-
cian’s teaching information base may be limited. The
emphasis on technology over basic clinical skills is wide-
spread. Teaching is left not uncommonly to technology-
based cardiologists; each emphasizes his/her own discipline
to the detriment of general knowledge acquisition and with
resulting transmission of various biases. For example, the
interventionalist promotes primary angioplasty over throm-
bolysis, the echocardiographer promotes stress echo over
other forms of stress imaging. This type of teaching lacks
balance and supports the concept that the cardiologist is a
technician. Protocols which do not allow the faculty or
trainees the opportunity to formulate or alter diagnostic or
treatment algorithms are probably detrimental. It is difficult
to know whether management by protocol has really im-
pacted the academic center.
The role of the cardiology fellow in teaching is not well
defined. Certainly service needs have reduced the available
teaching time for fellows as well as faculty. All fellows are
not equally skilled in teaching. Therefore, fellowship pro-
grams should foster teaching skills, as these skills will be
important regardless of the fellow’s subsequent role in
formal academic medicine or practice. There is a role for
“Fellows Conferences” with house staff and medical student
teams that occur on a regular basis. Fellows could provide
some of the core knowledge that may otherwise not be
provided (such as the physiology of heart failure) or could
serve as a resource for providing, for example, up-to-date
clinical trials material. Just as research time is protected, this
fellow educator time would have to be protected.
The academic reward for teaching continues to be diffi-
cult to assess despite acknowledgment of its value (11).
Objective measurements of teaching effectiveness are diffi-
cult to obtain due to the lack of adequate standards for
teaching evaluations. Educational research in this area is
limited, and more is needed.
Financial support of faculty with major teaching time
commitments is a problem. Specific budgets to support
teaching have not been developed in many institutions
(despite the fact that teaching is a major raison d’eˆtre of
medical schools). This has limited the capability of divisions
of cardiology, departments of medicine and pediatrics and
schools of medicine to support teaching activity. Therefore,
many clinician–educators are required to spend more and
more time in patient-related activities to “cover their salary.”
The financial cost of education in the 21st century must
be clearly defined (12). State support of medical school
graduate education needs to improve. Postgraduate (special-
ty and subspecialty) educational costs must be borne by all
health care payers and not Medicare alone. Institutional
support of postgraduate education (trainees’ salaries and
faculty support) must be standardized, as these trainees
provide valuable services to their institutions and will be a
valuable resource to the community. To pursue these
changes, the academic cardiology unit must develop accu-
rate cost-accounting methods for its teaching activities.
Training programs which do not have a strong commit-
ment to education as opposed to service should be elimi-
nated. The Residency Review Committee must be increas-
ingly stringent in this activity and be supported by the
medical community.
CORRECTIVE MEASURES
Better transition to an outpatient model. Over the past
several years, an increasing proportion of clinical cardiac
care has been conducted in ambulatory care settings rather
than in hospital inpatient facilities. This is evident by the
10% to 20% decrease in the number of bed days of care over
the past 2 years. Increasingly, specialized cardiac care is
being provided to ambulatory patients, and procedures such
as transesophageal echocardiograms and cardiac catheter-
izations are now routinely performed on an outpatient basis.
In addition, the recent proliferation of chest pain units to
evaluate patients with acute chest pain often obviates the
need to admit patients who, in the past, were admitted to a
telemetry or coronary care unit.
Thus, strategies must be developed to educate medical
students, house staff and cardiology fellows in this changing
health care arena. It is important for the academic cardiol-
ogy unit to determine what clinical sites are most appropri-
ate to be used in teaching different segments of the
curriculum so that students and trainees are able to practice
in settings where patients actually receive their care. The
issues for cardiology teaching are the same for general
medical education, that is, 1) Where should the sites be
located? Should they be centralized or dispersed? 2) What
resources will be required? and 3) What are the finances of
the ambulatory sites and how should these costs be split
among the various involved parties which include the
cardiology unit, the departments of medicine or pediatrics,
the medical school, the hospital and the insurer?
Enhanced prestige of teaching. A faculty appointment in
the cardiology division of most medical schools includes an
obligation to teach. Teaching efforts are generally moni-
tored by the departments of medicine or pediatrics and/or
the cardiology division, although the process is not well
defined and varies widely from institution to institution. In
the case of volunteer faculty, this appointment usually offers
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no compensation. Thus, rewards for teaching must be
developed and must be administered with fairness and
equity.
For full-time faculty paid by the medical school, a
different issue arises, namely, the protection of income of
faculty who teach extensively and who therefore give up
valuable research and clinical practice time. Because the
clinical faculty now have increased demands on revenue
generation, they have less time to teach medical students,
house staff and cardiology fellows. This is especially true in
cardiology divisions, which often generate large amounts of
money and which are called upon to support not only
themselves but also less “profitable” divisions within the
parent department. Some studies have suggested that faculty
who are simultaneously seeing patients and teaching stu-
dents and trainees have decreased clinical productivity.
Although this is not unexpected, it becomes a difficult issue
because of increased demands for greater efficiency and cost
containment, particularly by managed care programs. Thus,
for full-time faculty members, the time spent teaching
represents a true opportunity cost. It is becoming increas-
ingly difficult to subsidize the teaching faculty as depart-
mental and divisional surpluses disappear, yet not to do so
endangers not only the academic mission, but also the entire
definition and role of the profession.
Innovations in teaching methods and evaluation tech-
niques. There is widespread perception that cardiology
teaching today emphasizes technology to the detriment of
basic clinical skills (see above). It is therefore necessary for
program directors to take bold and innovative steps to
redress this anomaly. Ideally, clinical cardiology teaching
should be the responsibility of the “general” or “clinical”
cardiologist who would teach the “approach” to diagnosis
and management of cardiovascular disease. A specific aspect
of the patient’s diagnosis/management could subsequently
be turned over to a technology-based cardiologist who
would (in this setting) have the opportunity to impart his
knowledge to the trainees.
The academic cardiology unit of the future must also
embrace new ways of conducting “teaching” and “work”
rounds. A major issue is that of continuity of patient care
and teaching experience of faculty. The “occasional” teach-
ing attending physician experience will gradually diminish
and teaching will be conducted by faculty dedicated to this
activity. Similarly, new ways of conducting efficient and
effective teaching rounds need to be tried and implemented.
Combining effective teaching with efficient patient care will
be the measure of a successful teaching program in the
future.
The lack of adequate patient volume with characteristic
valvular physical findings (see above) can be and should be
corrected with the more widespread use of modern teaching
tools: audio tapes, video tapes, “Harvey” mannequins, inter-
active computer software and so forth. Although many of
these aids are available, their use has not been integrated in
the day-to-day teaching of clinical cardiology (13,14).
Finally, each training program could conduct its own
examination of the clinical skills of the trainees akin to the
“in service” examination internal medicine residents are
required to take. Such an examination would help the
trainees ascertain their weaknesses and help the program
director assess the quality of the training program.
Financial support. Graduate medical education funding
has traditionally been financed from a variety of sources
including Medicare, training grants and faculty practice
plans. With the exception of Medicare, it is often difficult to
quantitate the precise magnitude of such support. In fiscal
year 1996, for example, Medicare spent $6.6 billion to
support costs related to training students and residents.
Medicare payments to support graduate medical education
are divided into two major components: direct and indirect
graduate medical education. Direct graduate medical edu-
cation funds are payments made by Medicare directly to
teaching hospitals based on 1984 historical costs to cover
the salaries for residents, supervisory personnel and other
associated costs to maintain a residency program. A pay-
ment is made for each full-time resident; for some subspe-
cialty residents, the payments are down-weighted to provide
disincentives for this type of training. Indirect graduate
medical education funds are not based on identifiable costs.
Rather, they are intended to support teaching hospitals and
to compensate them for the higher costs that training
programs incur. Thus, indirect graduate medical education
payments are meant to compensate for the fact that sicker
patients are generally admitted to teaching hospitals, that
additional tests are often ordered and that special care units
are required. Hospitals are paid indirect graduate medical
education costs through annualized Division of Research
Grants payments. In addition, Medicare payments provide
funds to pay supervisory physicians (Part A) and for services
rendered directly by full-time and private practice physi-
cians.
In some cases, Medicare payments are capitated, in that
hospitals receive a per capita prepaid premium. This is a
negotiated rate unrelated to actual services consumed, and
this payment usually includes the graduate medical educa-
tion funds. The Institute of Medicine, in its April 9, 1997
report, identified several issues for future funding by gov-
ernmental programs. These points include 1) continued
desirability of graduate medical education funding, 2) the
need for relative neutrality of the payments in trying to
shape the workforce, 3) the need for each payer to contrib-
ute proportionately to support graduate medical education,
4) the need for reasonably consistent payments across
different institutions, and 5) the need for transition to any
new distribution scheme to be gradual and nondisruptive
(15).
The Institute of Medicine’s plan is also noteworthy in
that it suggested the use of a defined fund to support
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graduate medical education which is separate from the
Medicare Division of Research Grants payment system and
from capitation. Further it does not attempt workforce
restructuring, it sets a uniform price per trainee and it is
more responsive to possible future changes in health care
delivery.
In contrast, private sector payers are under pressure to
control costs; this has caused many such payers to deny
payment for training costs, thus putting teaching institu-
tions at risk. Further, this attempts to shift the burden of
educational costs to government payers like Medicare, and
the Department of Veterans Affairs Healthcare System at a
time when their resources are being reduced.
Medicaid represents a federal–state partnership that del-
egates management authority to each state. The current
practices for supporting graduate medical education vary
widely. For example, New York State provides $500 million
annually, whereas California does not use its Medicaid
funds in this manner. Thirty-seven of the 50 states do
contribute to graduate medical education support. Since
private payers have not isolated the educational support, the
costs are distributed as a part of the gross premium. In most
states private payers pay a higher premium to teaching
hospitals as a means of supporting graduate medical educa-
tion.
Capitated care, which is becoming increasingly wide-
spread, has a definite impact on academic cardiology, even
though an academic cardiology unit may have several
intrinsic advantages over a nonacademic system. The main
advantage is perceived quality of care, which, according to
the Healthcare Advisory Board, is the single most powerful
tool for attracting cardiac admissions and for building
program volume. Thus, important factors in operating a
successful academic cardiology program include the pres-
ence of high quality physicians, the presence of a physical
plant with state-of-the-art facilities, a commitment to
research which ensures access to state-of-the-art devices and
the availability of investigational drugs.
In summary, it appears that the nation and most state
governments are prepared to support graduate medical
education at a reduced level, but in return, will demand
more accountability for the expenditures and require that
emphasis on specialization and academic development be
balanced with programs designed to support “public goods.”
In the current era, these usually are represented by a need to
increase the output of generalists, to reduce the output and
distribution of selected specialists, to redistribute patient
care and medical education to ambulatory care and other
community sites and to increase the representation of
minority and other socially disadvantaged populations in the
medical profession.
For academic cardiology, these changes need not portend
a loss of its stature, importance or survival. Rather, academic
cardiology is recognized and appreciated for its many
tremendous accomplishments, credibility and visibility.
Thus, it has an opportunity to position itself to use its
talented workforce to integrate better the continuum of
patient care, research and education through a network or
system that incorporates the resources of the core academic
center, ambulatory care sites (urban and rural) and appro-
priate community health care sites. Academic cardiology, of
all of the medical subspecialties, is probably better prepared
and able to respond to the evolving changes in medical
education than are most other medical subspecialties.
CONCLUSIONS
Effective teaching is fundamentally important to the future
of academic cardiology. Recent changes in the delivery of
health care have had major impact on the capability of
clinician–educators to function as effective teachers. This
has occurred in the setting of increasing complexity of the
specialty which in itself mandates the need for high quality
teachers with sufficient time to impart new information and
techniques. Innovative strategies will be required to resolve
this problem.
RECOMMENDATIONS
The academic cardiology unit must:
1. Promote and develop excellence in teaching.
2. Provide balance between cognitive/clinical and technical
skills.
3. Develop and incorporate methods of evaluating effec-
tiveness of teaching.
4. Insure that the training curriculum of medical students,
residents and fellows includes appropriate cardiovascular
content and is periodically reassessed.
5. Develop appropriate incentives to enhance the academic
value of teaching. Such incentives include financial,
professional (promotion) and personal rewards.
6. Develop and support appropriate promotion criteria for
clinician–educators.
7. Guarantee faculty sufficient time and resources (e.g.,
conference space, teaching materials and so forth) de-
voted to effective teaching at all educational sites.
8. Develop and implement innovative teaching tools and
methods.
9. Work with other components of the health care delivery
system to insure an adequate patient base for education.
To assist academic units to accomplish these goals, the
American College of Cardiology must take a leadership
position in:
1. Educating the lay public, government, political establish-
ment, media, payers, industry and health care providers
on the importance of medical teaching and education.
2. Helping to identify the costs of education.
3. Developing a national forum to “teach the teacher.”
4. Working with other groups to identify and ensure an
adequate and stable funding base for medical education
(e.g., all payer pool).
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5. Assisting academic units with the development of inno-
vative teaching and evaluation techniques.
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Task Force 4: Faculty
Joseph S. Alpert, MD, FACC, Co-Chair, Carl V. Leier, MD, FACC, Co-Chair
THE FACULTY OF THE ACADEMIC
CARDIOLOGY DIVISIONS IN THE 21ST CENTURY
Age-adjusted cardiovascular mortality has declined by 50%
over the past 50 years. This remarkable accomplishment has
been driven by the research and teaching of academic
faculty. However, cardiovascular disease still accounts for
50% of morbidity and mortality in the U.S. Since cardio-
vascular disease is particularly prevalent in the elderly, the
number of patients who will require cardiac care will
increase in the 21st century. The rapid progress in under-
standing molecular and cellular pathophysiology provides
unprecedented opportunities to bring improved care to
patients.
Although the profile of the academic cardiology faculty
varies considerably between institutions, certain principles
and aspects pertain to all. Advances in cardiovascular
research require major participation by academic cardiolo-
gists. Important basic science work is often performed in
cardiology sections. Academic cardiologists frequently play
a critical role in translating basic science advances into
clinical applications. Depending on faculty interest, avail-
able resources and financial support, divisions will vary with
respect to their activities in basic, translational and clinical
trial research; but each division will have to participate in
research to bring current cardiovascular advances to pa-
tients, trainees and their community.
The academic cardiologist is essential in the cardiovascu-
lar educational process. He/she must remain committed to
teaching trainees various problem-solving concepts and
approaches, as well as critically appraise current practice and
advances in the field. The faculty of cardiology divisions
must foster a research environment and offer the highest
standard of clinical care. An adequate number of patients is
crucial to this mission. Fiscal support for time spent per-
forming both teaching and research must be identified.
The impact of the socioeconomic forces and changes over
the past decade on academic cardiology faculty has been
remarkable. The daily activities of most academic faculty
have been modified considerably; in general, time and effort
formerly dedicated to research, scholarship and professional
development have been shifted to patient care duties. In
brief, academic faculty are now expected to perform research
and to teach as before while increasing their clinical work-
load to nearly the same level as our colleagues in nonaca-
demic practice and at a far lower remuneration. This
represents a serious threat to the stability of academic
divisions and to the survival of academic cardiology.
This section of Bethesda Conference #30 focuses on
many of the problems of academic faculty in cardiology
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(e.g., inadequate salaries, job insecurity, promotion and
tenure, depressed morale), potential solutions for such
problems and a prospectus for a successful future for
academic cardiology faculty and divisions.
THREATS TO SALARY STABILITY,
JOB SECURITY AND MORALE
There can be little doubt that academic specialists in
general, and cardiologists in particular, have felt the world
closing in on them both financially and with respect to job
security. Trainees lament that their options are limited
compared to the past, and faculty feel threatened at every
turn from decreasing reimbursement, increasing overhead,
enhanced documentation requirements and restricted access
to primary care colleagues. In many academic centers,
faculties have experienced “rightsizing,” falling compensa-
tion or threats of both.
How this situation has come about is not difficult to
ascertain. From 1988 to 1993, there was double-digit
inflation in the cost of health care to employers and
government agencies. This escalation in cost could not be
sustained if company and government budgets were to be
balanced. This led to a demand for decreasing health care
costs. The result of this demand was the rapid growth of
managed care. Implementation of managed care carries a
number of direct consequences for all physicians and par-
ticularly for academic practices where the costs of teaching
and research have been borne in part by clinical revenue.
The number of dollars available for a unit of clinical work
(e.g., clinic visits, electrocardiograms or angioplasty) is
decreasing rapidly. Second, as more and more patients are
managed by primary care physicians and access to specialists
becomes limited, the number of services provided by spe-
cialists decreases. This leads to a diminished need for
cardiologists in managed care markets, as noted in Califor-
nia and other regions of the country with high managed care
penetration. This has occurred at the same time that there
has been significant growth in the number of cardiology
fellows.
A few examples will highlight the concerns. Figure 1
shows the stages in market development for managed care
in a geographic region. In early markets, the number of
catheterizations performed per 1,000 covered commercial
lives (age ,65 years) is approximately 2.4, with $901
available per covered member per month. Under these
market conditions, one cardiologist who performs cardiac
catheterization would need about 18,000 covered lives to
stay busy full time. As can be seen, as the managed care
market “matures,” the changes become dramatic. At end
stage, where there are fully integrated systems taking full
risk capitated contracts, the number of catheterizations falls
to only 1 per 1,000 insurees, dollars available are cut in half
and 58,000 people are needed to keep a single catheterizing
cardiologist busy. Thus, there is a perceived diminished
need for cardiologists. This, coupled with the fact that there
is rapidly decreasing reimbursement, has led to considerable
anxiety on the part of cardiology faculty and fellows.
These changes have forced academic units to begin to
cost-account faculty time in terms of research, teaching and
clinical services. The goal is to make each component pay
for itself, since clinical revenue can no longer subsidize
teaching and research.
One consequence of decreasing reimbursement is an
increase in the amount of work performed by faculty to help
maintain economic stability. This has resulted in the shift to
more clinical and less research faculty in departments of
medicine and divisions of cardiology. Faculty are being
asked to increase their clinical workload to emulate their
colleagues in private practice but without the same personal
remuneration. Figure 2 shows concrete examples of what
the Division of Cardiology at Duke has done over the past
6 years. From 1992 to 1997, charges which can be taken as
a surrogate for patient care activity (price increases over this
time have been in the 1% to 3% per year range) have
increased an average of 8.3% per year for a total increase of
49.8%. Therefore, with approximately the same number of
faculty, Duke cardiologists did 38% to 45% more clinical
work over a span of 5 years. Over that same period of time,
total receipts fell 6.3%. These results are typical of those
observed across the country and are obviously very disheart-
Figure 1. Stages in market development for managed care. Black
bars: catheterizations per 1,000 population. Light bars:
Dollars 3 100 available per covered patient per month. Dark bars:
Population 3 100,000 needed to support a catheterizing cardiol-
ogist.
Figure 2. Work versus pay. Bars (left to right): 1992, 1993, 1994,
1995, 1996, 1997.
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ening to cardiology faculty. In many academic institutions
this has led to flat or decreasing salaries and even decreases
in faculty size. If we look nationally at the trends in salaries
for cardiology at academic centers, the recent past has
shown little growth in compensation and, in some cases,
actual decreases.
These changes have led divisions of cardiology to reassess
the role and appropriate size of their faculty and their
mission. Programs have now limited the number of recruits,
and in some cases downsized. To meet our tripartite mission
of teaching, research and clinical care, it will be necessary to
find new revenue streams and to decrease expenses. In the
past, divisions of cardiology have been financial generators
for departments of medicine. This model is rapidly chang-
ing as cardiology income declines.
All of these forces have resulted in declining faculty
morale. This situation has contributed to increased faculty
turnover in recent years. To preserve the mission of aca-
demic cardiology, it is essential that we improve the morale
of our faculty. However, it would sound foolish to inform
faculty that “all is well.” Nevertheless, academic life is still
filled with many positive experiences: the intense satisfac-
tion of the faculty member who has just won her hard-
earned RO1 grant, the pleasure of hearing that your
promotion has been approved and the joy of interacting
with eager and enthusiastic medical students and house
staff. We as faculty need to develop a level of personal
equanimity that enables us to accept the bad news around us
and put it into appropriate perspective. Academic cardiology
will survive; our patients, our profession and our nation
require it. We must remember that we practice the most
advanced and sophisticated medicine in the world, that
cardiovascular research plumbs new and exciting depths
almost on a daily basis and that our students are as
intelligent and dedicated as ever. We can and will overcome
present circumstances.
THE APPROPRIATE NUMBER OF
CARDIOLOGY FACULTY FOR THE FUTURE
Over the past 20 years, there has been a substantial increase
in the number of full-time and part-time faculty members in
academic cardiology divisions throughout the United States.
The major impetus for this increase in faculty was the
emergence of subspecialty disciplines within cardiovascular
divisions as a result of advances in technology. The areas
that required specialized training and developed into sub-
specialties were echocardiography, nuclear cardiology, clin-
ical/interventional electrophysiology, coronary/valvular in-
terventional cardiology, heart failure/transplant cardiology,
preventive (risk factor modification) cardiology and vascular
medicine. Certificates of added qualification are or will be
granted by the Cardiovascular Board of the American Board
of Internal Medicine for electrophysiology and interven-
tional cardiology, since these subspecialties require an addi-
tional year of fellowship beyond the standard 3-year cardi-
ology fellowship training program.
To staff these new disciplines, full-time academic cardio-
vascular divisions needed more attending physicians to
provide clinical services, conduct research and train the next
generation of subspecialists. In addition, cardiology fellows
who were tracking to become “general cardiologists” needed
a liberal exposure to these specialized areas.
The Association of Professors of Cardiology has been
monitoring the number of full-time cardiology division
faculty in academic medical centers since 1992. Table 1
shows the number of faculty members per institution.
Between 1992 and 1997, the number of faculty per institu-
tion grew from 15.71 to 18.17 (Table 1).
Another stimulus for the increase in the number of
cardiology division faculty during the past 20 years is the
increased emphasis on the research mission of academic
medical centers. Many cardiology divisions actually changed
their name from “cardiology divisions” to “cardiovascular
divisions” after incorporating vascular medicine and vascular
biology into their academic mission. Research faculty in
cardiology divisions sought to participate in the revolution
in molecular biology and molecular genetics as it applied to
cardiovascular disease. The advances in molecular biology
stimulated increased recruitment of basic science faculty to
academic cardiovascular divisions. Many division chiefs in
academic cardiology sought to develop programs for the
training of MD investigators in molecular and cellular
biology. Many of these newly trained individuals remained
on the faculty of their respective institutions or were
recruited to academic centers elsewhere. Other stimuli for
the growth of research faculty included expansion of clinical
trials and technology development and assessment.
Unfortunately, a recent study has shown that faculty at
medical centers in competitive markets publish fewer scien-
tific articles compared to clinical investigators in less com-
petitive markets (1). The junior faculty members in the
highly competitive markets had greater clinical responsibil-
ities and, hence, less protected time for research.
The question that can now be asked is “how many faculty
do we really need?” The answer is at present unclear. The
total number of board certified or eligible cardiologists in
the U.S. has grown considerably during the past 25 to 30
Table 1. Number of Full-Time Cardiology Division Faculty in
Academic Medical Centers: Trends From 1992 to 1996
No.
Institutions*
No.
Faculty/Institution
1992–93 93/115 (81%) 15.71
1993–94 101/115 (88%) 16.19
1994–95 109/116 (94%) 17.22
1995–96 82/114 (72%) 18.54
1996–97 77/115 (67%) 18.17
*Number of institutions reporting data/total number of institutions in the Association
of Professors of Cardiology. (Data from the Association of Professors of Cardiology
Financial Database Project.)
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years. In 1970, there were 4,616 clinically active cardiologists
practicing in the United States, or 2.2/100,000 population. By
1993, the number of cardiologists in the United States had
risen to 14,125, or 5.7/100,000 (2). Today in the United
States, there are approximately 7.0 cardiologists per 100,000
population. Despite the well known constraints of managed
care, the number of patients seen by cardiologists continues to
grow. Contrary to intent, it is possible that despite managed
care, the referral of patients with cardiovascular disease to
cardiologists by primary care physicians might continue to
increase. Americans clearly want freedom of choice of physi-
cian including access to cardiologists. Additionally, as the
American population ages, cardiovascular-related illness will
increase. An increasing emphasis on quality and increasing
population at risk for cardiovascular disease might thus lead to
a greater demand for cardiologists, thereby placing pressure on
academic cardiology divisions to train more cardiologists.
However, given the conflicting forces, it is impossible to
predict accurately whether the demand for cardiologists will
increase, decrease or remain the same in the future.
Similarly, the number of faculty members needed for the
provision of high quality specialty care, state-of-the-art
research and training of the next generation of general
cardiologists, subspecialty cardiologists and internal medi-
cine residents is unknown. Certainly, there will be increased
utilization of nurse practitioners and physician assistants in
response to cost-cutting and cost-effective care norms. Of
interest are data provided by the American Board of
Internal Medicine showing that the number of first-year
cardiology fellows decreased from 858 to 736 between 1992
and 1996 at a time when the number of full-time faculty
members per academic training institution actually in-
creased (see Table 1) (3).
CHALLENGES TO PROMOTION AND TENURE
During the last two decades, academic health centers have
become increasingly dependent upon clinical activity for
revenue. In addition, competition for peer-reviewed re-
search grants has increased. These changes have led to
fundamental changes in faculty composition and activity.
Faculty engaged in clinical activities are under increasing
pressure to achieve clinical productivity. Because peer-
reviewed research funding is increasingly competitive, such
awards are now limited mostly to applicants who spend at
least 75% of their time on research.
Given the current situation, it is not surprising that the
nation’s academic health centers have struggled to confront
complex issues of faculty evaluation, recognition, promo-
tion, financial compensation and retention. The traditional
evaluation and promotion strategies of earlier times are no
longer applicable to the current needs of academic health
centers and the activity patterns of their faculty. The
incentives to forge a long-term academic career have
changed. Thus, there are a number of difficulties in the
evaluation, promotion and retention of faculty.
New Promotion Tracks
In response to the changing nature of the faculty, academic
health centers have modified their promotion tracks. Details
vary among institutions, but the general strategy is as
outlined below. In essence, the traditional tenure promotion
track has proved insufficient to cover the new activity
patterns of current faculty. The system has been supple-
mented with additional tracks.
Investigator track. This track, which has existed for de-
cades, predominantly recognizes research productivity as
judged by peer-reviewed grant funding and publications.
For the most part, faculty who engage in more than a token
amount of clinical activity are not able to achieve the
necessary research credentials to be competitive in this track.
Consequently, this track has often become the “basic
science” or bench research track. However, at some institu-
tions this track can include a highly productive clinical
investigator. Cardiologists who predominantly perform re-
search should be expected, after a 3- to 5-year start-up
period, to generate most of their salary through research
grants. The remaining salary would come from endowment
or institutional resources or the income of his/her modest
clinical activities. Resources would generally be made avail-
able for space, equipment, personnel and investigator salary
support over the first 3 to 5 years. The basic investigator
who is not able to achieve these financial guidelines cannot
expect to continue in the faculty ranks of most divisions or
must reduce research effort to the level of research support.
In addition to funding his/her own research program and
most of the salary stipend, the basic investigator is expected
to collaborate closely with the academic clinical faculty of
the division and other university faculty to enhance the
research prowess of the program and the division, and to
provide a research training program for cardiology fellows,
graduate students and postdoctoral associates. The basic
investigator, like the clinician, must be supported for his/her
teaching effort.
Clinician–scholar (clinician–investigator) track. This
track evolved in the 1980s and currently has become the
predominant promotional track for clinical faculty. Individ-
uals on the clinician–scholar track are expected to be
outstanding clinicians who contribute heavily to the insti-
tution’s teaching activity. The clinical faculty member
should be expected to do more than see patients and/or do
procedures. He/she should participate in multicenter trials
and ideally, eventually direct or codirect one or more of
these, generate a modest number of clinical reports and
teach students, house staff and fellows during part of his/her
day-to-day clinical activities. These expectations impart and
justify the term “academician” irrespective of whether he/
she is on the tenure track. The professional satisfaction of
the teaching role and study participation also serve to attract
faculty members to the division. These faculty members are
typically loyal to the academic mission, excellent teachers of
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clinical and bedside cardiology, extremely hard working,
respected clinicians and superb role models. Most divisions
will fail to thrive clinically, investigatively, academically and
financially without many faculty members serving in these
clinical roles and without a large patient population under
its care.
Valid and rigorous evaluation of performance on this
track has posed a complex challenge to institutions, since it
is often difficult to develop rigorous methodologies to
evaluate clinical and teaching performance. The number of
clinical faculty needed to develop a successful division will
vary widely depending on the location of the institution,
resources available, potential referral base, interaction with
referring physicians and local centers, Health Maintenance
Organization or managed care contracts (awarded and
under negotiation) and so forth. For most divisions, the
academic clinicians could constitute 50% or more of the
total faculty. For divisions that are community-based and
draw on practicing clinicians to cover the teaching needs or
the few divisions that are extremely well funded for research,
the central role and number of the geographic full-time
academic clinicians might be lower.
Clinician– educator track. In response to the increased
need for clinical activity by fully affiliated faculty, some
academic health centers have developed a third promotion
track. The principal mission of faculty on this track is to
engage in clinical practice and teach. Responsibilities for
scholarship are subsidiary. Whereas this track enables
institutions to hire, promote and retain clinical faculty
who do not publish, the relationship of this track to the
clinician– educator track is often less clearly defined. At
times there is competition for referrals between faculty on
the two tracks.
Affiliated clinical faculty. Traditionally, academic health
centers have had an abundance of affiliated clinical faculty.
These individuals are generally in private practice and are
not employed by the institution. They may have limited
teaching responsibilities and are not subject to the appoint-
ment and promotion requirements of the full-time faculty.
The fraction of the institution’s clinical activity and teaching
provided by these individuals varies depending upon the
overall organization of the medical center but in general is
not substantial. Criteria differ among institutions for ap-
pointment and promotion of affiliate faculty. Occasionally,
long-term affiliate faculty leave private practice and join one
of the above-mentioned academic tracks, thereby becoming
employees of the academic medical center.
Challenges to Meeting Promotional
Requirements for Fully Affiliated Faculty
Requisites to be a successful academic cardiologist. The
traditional successful academic cardiologist was said to be
proficient in three areas: research, clinical skill and teaching.
Each of these entities requires separate skills, and there is
incomplete overlap between them, that is, development of
successful research productivity does not necessarily confer
excellent clinical skills or teaching proficiency. Success in
the research arena, basic or clinical, requires training,
creativity and the application of a sufficient fraction of the
individual’s time to generate data, analyze it and prepare
manuscripts reporting the results. Success as a clinician
requires sufficient experience to acquire the requisite clinical
acumen and skills, an ongoing clinical practice and contin-
uous self-education to maintain and extend proficiency.
Success as an educator requires the motivation to teach,
in-depth knowledge of the subject and the acquisition of the
necessary skills to communicate concepts to students. Real
success in all three areas is probably no longer realistic; even
excellence in two areas is difficult to achieve.
Research requirements. Successful research requires fund-
ing. It is no longer possible to conduct important research in
one’s spare time using borrowed facilities. Consequently, it
is necessary to secure funding to support both the costs of
the research and the faculty member’s salary. Securing
research funding requires the development of requisite
credentials and the production of credible proposals to
funding organizations. Consequently, an individual in the
early stages of his or her career must devote the majority of
their time and effort to acquire such skills and credentials.
Such an effort allocation is not consistent with the time
needed to develop and maintain top-flight clinical creden-
tials. Accordingly, individuals who seek successful careers as
investigators must devote the majority of their time to that
activity.
Clinical demands. Individuals who pursue clinical career
tracks in cardiology must confront three axioms:
● Clinical cardiology is sufficiently complex and demanding
that one cannot achieve and maintain proficiency without
practicing actively.
● The salary support for academic clinicians is derived
almost exclusively from their clinical revenues.
● Clinical cardiology practice is punctuated with frequent
emergencies which make it difficult to compartmentalize
one’s time.
Consequently, academic clinical cardiologists must en-
gage in relatively high volume clinical practice. Such activity
patterns tend to demand a large fraction of an individual’s
time and may be difficult to differentiate from the activity
patterns of many clinicians in nonacademic practice.
Faculty assessment and performance improvement. Al-
though cardiology faculty members may initially be uncom-
fortable with the concept of assessment of performance,
formal evaluation of all areas of the mission are becoming
more common. Such assessments can be used to recognize
clinical achievement with appropriate reward, and to point
out opportunities for improvement. A number of clinical
benchmarks can be employed in this analysis. For example,
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the relative value units (RVUs) generated by an academic
cardiologist will approach those of a practicing cardiologist
with modifications for teaching and research effort.
Research metrics (grant dollars and publications) are
more standardized for the promotion process than are those
employed for clinical effort. However, evidence of indepen-
dent investigation is becoming less important in the current
era, with collaborative investigational projects the common-
est form of biomedical research. Much work remains to be
done with respect to evaluation of educational performance,
although standardized student evaluations and quantitation
of educational time and effort are becoming more common.
Service to a variety of university, community and national
organizations must be recognized.
Such formal evaluations can improve mentoring and lead
to valuable discussions of the individual faculty member’s
goals and how these relate to those of the department and of
the institution.
Forces acting on faculty. RESEARCH FACULTY. A research
faculty member’s entire career depends upon his/her re-
search productivity. Such an individual’s performance eval-
uation will be heavily influenced by research funding and
publications. Consequently, such an individual has little
incentive to participate in teaching activities or to develop
teaching skills. A research faculty member has two principal
career hurdles: to establish a successful program which has
consistent productivity and sustained funding; and to main-
tain that output over a career. The latter is perhaps the more
daunting challenge since it requires sustained creativity.
CLINICAL FACULTY. A faculty member in the clinician–
educator track must achieve clinical excellence and produce
sufficient scholarly output so that he/she can be distin-
guished from a nonacademic clinician. Currently, clinician–
educators are subject to substantial clinical productivity
requirements. These demands reduce the time available to
engage in scholarly work. Thus, there are many clinician–
educators who are devoting virtually all of their time and
energy to clinical activity and are not able to achieve
requisite scholarly production.
Faculty Development and Counseling
For faculty to develop a long-term, successful and satisfying
career, considerable mentoring and faculty development are
essential. Many academic institutions lack effective pro-
grams in this area. All too often, new faculty are left on their
own, floundering as they attempt to develop their careers. In
addition, some cardiology faculty will require training in
nonclinical areas such as informatics, decision analysis,
educational theory, leadership and business management
practices. The latter two areas are particularly relevant for
divisional leaders.
Aligning Faculty Incentives With Mission and Goals
Faculty need to be organized and perform as a business unit,
with defined business lines (teaching, research, patient care)
integrated and managed to accomplish objectives supporting
the mission and vision of the division. Faculty need to be
intimately involved in all aspects of divisional planning and
decision making.
Total compensation including salary supplements or in-
centive bonuses for faculty should reward productivity and
be aligned with what is of value to the division and the
institution. Incentive plans for highly productive faculty
should be based not only on financial performance (i.e., total
revenue generation minus expenses), but on RVU genera-
tion with significant credit given to evaluation and manage-
ment RVUs. Some institutions have introduced “multiplier”
factors, whereby new patient visits and new consultations
are assigned a higher value for incentive plan calculations
than the standard RVUs assigned to those Current Proce-
dural Terminology (CPT) codes. Other creative approaches
to motivate faculty performance might include salary sup-
plements for obtaining extramural research funding or
receiving teaching awards. Incentives can also be created to
attract and retain new and current faculty. For example, the
division could create an equity fund with contributions
made per year of faculty service. This is comparable to
approaches undertaken in private practice groups where
members of the group buy into the practice. Such a plan
represents a cumulative investment by the faculty member
that can be withdrawn at retirement or when the faculty
member leaves the institution. Other creative incentive
packages should be developed to motivate excellence in
teaching and research.
Supplemental Funding of Teaching and Research
Although much of cardiology teaching occurs as part of
day-to-day clinical activity (e.g., ward rounds, reading
echocardiograms), dedicated time must often be set aside for
the delivery of more didactic education. The three- to
five-year start-up period for the new faculty member with a
primary focus on cardiovascular research is not sufficient to
generate an adequate income (clinical or research) to sup-
port that salary line.
Funding for these teaching and research activities
remains a challenge and a serious threat to the mission
and future of cardiology divisions. To date, these monies
have been largely obtained from divisional clinical in-
come. Clinical income has decreased to the level where
these monies are no longer adequate or even available for
teaching and research. Negotiating a reduction in cardi-
ology financial support rendered to the departmental
budget should be readdressed for the purpose of redirect-
ing these dollars to the teaching and research mission of
the cardiology division. Other sources of funding must
include departmental and medical school teaching and
start-up funds. Adding release-time salary support to
grants (including industrial grants) should be encouraged.
Endowments need to be considered for ongoing funding
for teaching and research and are likely to become the
major solution in the future.
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ACADEMIC PEDIATRIC CARDIAC CENTERS
The configuration and needs of academic programs along
pediatric cardiac service lines differ in some important
features from adult cardiac programs. These features relate
to the special demography of pediatric cardiovascular disease
and to issues of child health care.
The most prominent cardiac problem in childhood is
congenital heart disease. These defects are relatively rare,
approximately 1% of the population at birth. As a rough
estimate, 3% to 5% of children will see a pediatric cardiol-
ogist at some time, but the majority of these visits are related
to evaluation of nonpathologic cardiac complaints or find-
ings such as an innocent murmur. The rare, significant
cardiac anomalies are often highly complex and require
teams of cardiovascular specialists with differing skill sets
such as echocardiography, electrophysiology, interventional
catheterization and cardiovascular surgery. As a result,
pediatric cardiologists and cardiac surgeons are congregated
in high resource centers associated with medical schools or
stand-alone children’s hospitals. Service needs in the rest of
the country are provided by outreach from the academic
center rather than by collaboration with community subspe-
cialists.
Due to the rare nature of congenital heart disease, only
800 to 900 board certified pediatric cardiologists are prac-
ticing in this country at the present time. Although approx-
imately half of practicing pediatric cardiologists are in
office-based practices, they are usually associated with an
academic medical center through some formal or informal
relationship. Although workload for pediatric cardiologists
has risen to the point that research and educational objec-
tives are not being met, the number of jobs offered at
academic centers are limited, usually as a result of inade-
quate financial resources.
There is a strong partnership between pediatric cardiol-
ogists and cardiovascular surgeons, since the dominant
patient groups require close collaboration in the planning of
medical and surgical intervention and in perioperative and
postoperative management. Other groups that collaborate
in patient care are neonatologists, obstetricians (maternal
fetal medicine specialists), intensivists and adult cardiolo-
gists.
Due to the complex nature of congenital disease, there is
little overlap in duties between pediatric cardiologists and
general pediatricians, thus there is no competition between
groups.
Clinical service reimbursement for congenital cardiac care
is based on Medicare reimbursement for acquired disease.
The time and overhead costs of this care are not appropri-
ately represented, and there is little opportunity to compen-
sate by increased volume of care since disease is rare.
Therefore, income of pediatric cardiologists is roughly 55%
of that of adult cardiovascular specialists. Moreover, income
of pediatric cardiologists often heavily subsidizes depart-
ments of pediatrics, because income from other pediatric
specialists and subspecialists is even more limited. As a
result, there is a critical lack of resources to use as start-up
or bridging funding for basic or clinical science.
The combined factors of restricted financial resources and
the time requirements for outreach as well as extremely
complex care result in low research productivity. In addi-
tion, trainees are often attracted to the field by the dramatic
clinical appearance of heart disease in the newborn and the
gratifying therapeutic results. Thus, the field does not favor
individuals who are willing to restrict their clinical effort to
the 10% to 20% necessary to be grant competitive. As a
result, of 117 National Institutes of Health grants in areas
related to pediatric cardiology, only nine awards of any type
are held by eight pediatric cardiologists.
The number of pediatric residents choosing subspecialty
training is decreasing. Debt burden is a significant factor in
discouraging trainees from pursuing an academic, research-
based career when incomes are low. Thus, the outlook for
funded investigators in the field is bleak and likely to worsen
in the future.
Another consequence of a field based on the management
of rare, complex disease is that the numbers of patients
necessary to achieve excellence and the spectrum of experi-
ences required to support training make the academic
centers very sensitive to competition from other groups.
Academic pediatric cardiology groups require a large pop-
ulation (at least 1 million) to support the necessary experi-
ence in technical procedures. Surgical mortality for congen-
ital heart disease has been directly related to patient volume
in several large studies. In addition to complex disease,
academic centers need significant patient volume with a low
severity of disease on which to base training of generalist
pediatricians.
To preserve excellence of clinical service, education and
research in pediatric cardiac academic centers, the following
needs must be addressed:
1. Patient care reimbursement must be matched to the real
costs of service delivery in this complex patient popula-
tion.
2. Patient access to academic medical centers must not be
restricted, because of the extreme sensitivity of clinical
outcomes and educational needs to patient volume. The
organization of integrated health systems should be
carried out in a way that will regionalize procedural care
to high resource centers.
3. Specific funding and/or debt forgiveness will be required
to build sufficient research strength within pediatric
cardiology.
Training in adult cardiology is increasingly focused on the
care of acquired heart disease. As a result, relatively little
attention is paid to congenital heart disease in adults.
Concurrently, increasing numbers of children with congen-
ital heart disease are surviving to adulthood and require care.
Accordingly, steps should be taken to assure that there is an
appropriate reservoir of adult cardiologists with sufficient
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expertise in congenital heart disease to care for these
patients.
WOMEN IN ACADEMIC CARDIOLOGY
Women currently make up 5% of practicing adult cardiol-
ogists and 10% of adult cardiology trainees. In pediatric
cardiology, the proportion of women is much higher.
Forty-nine percent of current pediatric cardiology trainees
are women. Work profiles of women and men were recently
described by Limacher et al. in a study sponsored by the
American College of Cardiology (4). A number of impor-
tant differences between a sample of 964 female American
College of Cardiology members (including pediatric cardi-
ologists) and an age-matched sample of 1,199 male mem-
bers were found in this study. They are summarized below.
Women are more likely to describe their primary or
secondary role as clinical/noninvasive. Women practiced
clinical cardiology as a primary role in 79% of respondents
versus 58% of male respondents. They described themselves
as echocardiographers more often (31% vs. 19%); and they
more often described themselves as researchers (12% vs.
8%).
Only 8% of women cardiologists practice part-time.
Seventy-six percent of women had children; only 1% had
on-site child care facilities.
Factors that need to be considered in recruiting and
retaining women include 1) assuring equality, 2) advance-
ment judged on merit, and 3) flexibility in scheduling
responsibilities. Women faculty share concerns about salary
with their male counterparts, but they are also more inter-
ested in being able to negotiate hours and support staff.
Women faculty also have special interests in administrative
duties, and national recognition.
The pattern that emerges is that women have greater
family responsibilities and they must work harder to achieve
academic development and national recognition. As more
women have entered medical school and the generalist pool
from which cardiologists are recruited, these issues will
assume greater importance. Potential corrective measures
include more formal mentoring, further problem identifica-
tion and leadership training/faculty development.
Since women more often enter academic cardiology, it is
important to consider methods for addressing their interests
and goals with academic career development. This effort will
be rewarded because of the work profile of women which
emphasizes clinical cardiology and research and also is
responsive to increasing patient demand for women physi-
cians.
MINORITIES IN ACADEMIC CARDIOLOGY
Minorities, as defined and monitored by the Association of
American Medical Colleges, include Blacks, Mexican
Americans, mainland Puerto Ricans and American Indians.
Minorities are dramatically underrepresented in academic
cardiology. In addition to underrepresentation in medical
training, low percentages of minorities enter medical fac-
ulty. In 1997, 1,770 or roughly 11%, of matriculants to U.S.
medical schools were minorities. This is about half the
proportion expected if representation in medical training
parallels representation in the U.S. population. In addition,
despite yearly U.S. minority medical school graduates in
excess of 1,000 for the last two decades, only 2,303
minorities are current members of faculty in majority
medical schools. There are additionally 1,000 minority
faculty at historically Black and Puerto Rican medical
schools.
Diversity in ethnic and cultural background, as well as
gender of physicians and medical faculty is critical to achieve
high quality care for all U.S. populations and to articulate all
perspectives in discussions and priority setting in medical
research and health policy. Minority physicians play a key
role in improving access for minorities and the economically
disadvantaged, and they provide cultural competence. Fur-
thermore, the burden of cardiovascular diseases is dispro-
portionate in minority populations, with excess cardiovas-
cular morbidity and mortality in U.S. minority populations.
Cardiology training programs should seek qualified minor-
ity candidates, facilitate identification of suitable mentors
and target faculty training and development for minority
candidates.
RECOMMENDATIONS:
Academic medical centers
a. Faculty need to be organized and perform as a “business
unit” with specific activity lines, that is teaching, research
and patient care, which are integrated and managed in
order to accomplish the divisional/departmental mission
and objectives. Faculty input and involvement is essential
in defining these goals and their implementation.
b. Create different financial incentive packages for faculty
members dependent on their predominant area of con-
centration: clinical, teaching or research. Thus, individ-
uals who concentrate on research might receive a salary
bonus dependent on successful grant applications; clini-
cians would be rewarded for productivity; and educators
would receive incentives for recognized excellence in
teaching.
c. Institutional salary support for faculty time spent teach-
ing students, house officers and fellows. A variety of
formulae already exist in different academic institutions
for teaching support to faculty salaries.
d. Support protected research time for faculty members. It
is particularly important for junior faculty members to be
supported. Substantial quantities of protected time are
essential to develop incipient research careers. Ulti-
mately, endowed funds would seem the most secure
method for achieving this goal.
e. Revise promotion and tenure guidelines for academic
institutions to recognize increased clinical demands.
Thus, clinical investigator and clinical educator tracks
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should be implemented. Tenure and promotion decisions
should be made in an environment where clinical de-
mands on faculty time are recognized.
f. Time must be preserved and programs must be created
for faculty development. Such programs include research
mentoring, teaching effectiveness, professional develop-
ment (e.g., continuing medical education), leadership and
administrative skills. However, not all faculty will need
development or coaching in each of these areas. Addi-
tional skills and processes worthy of consideration include
organizational dynamics, best business principles and
practices, team-based functional units, essentials of citi-
zenship in an academic division and related areas.
The American College of Cardiology
a. The American College of Cardiology should appoint an
ad hoc committee whose charge is to develop evaluation
instruments for promotion and incentives for cardiology
faculty in the following areas: 1) teaching, 2) clinical
activity, and 3) service. Guidelines and applicable bench-
marks are desperately needed in these areas.
b. The American College of Cardiology should develop an
information clearinghouse detailing specific imple-
mented strategies of various academic institutions con-
cerning 1) faculty development, 2) faculty compensation,
3) assessment of faculty performance, 4) product lines,
and 5) new approaches to health care delivery, including
physician extenders, hospitalists, full-time clinical faculty
and so forth.
c. The American College of Cardiology should continue to
educate the lay public, politicians and media in support of
efforts that seek to ensure appropriate reimbursement for
patients with congenital heart disease. This would allow
the clinical care of these complex patients to be supported
without cross subsidy from other endeavors. Supporting
the academic faculty who care for these patients would
allow for the development of a career track in congenital
heart disease within adult cardiovascular medicine and
would stabilize the faculty of pediatric cardiology pro-
grams who care for many of these complex patients.
d. The American College of Cardiology should lobby the
National Institutes of Health to establish an appropriate
number of research training and career development
awards for pediatric cardiologists.
Academic cardiology leadership
a. Academic leadership should recruit more women into
sections of cardiovascular medicine and address the
special needs and concerns of women in academic cardi-
ology. Underrepresentation of women will continue un-
less training programs adopt policies to reduce barriers to
women selecting and successfully completing training in
cardiology. Programs should facilitate identification of
suitable mentors for women and adoption of policies for
family leave during training.
b. Academic leadership should encourage the recruitment,
and address the needs, concerns and retention of under-
represented minorities in academic cardiology. A variety
of innovative programs, for example, National Institutes
of Health minority supplemental grants, exist to support
recruitment and retention of minority faculty. Mentoring
of minority faculty members is essential to foster appro-
priate professional growth and development.
c. Clinical faculty need a certain amount of protected time
to develop some academic productivity. The quantity of
time is usually modest, and academic productivity should
be broadly defined. It may include development of
teaching syllabi, computerized teaching aids, case reports
and case series and so on.
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